WO2015070746A1 - Test strip card marked by quantum dots - Google Patents
Test strip card marked by quantum dots Download PDFInfo
- Publication number
- WO2015070746A1 WO2015070746A1 PCT/CN2014/090849 CN2014090849W WO2015070746A1 WO 2015070746 A1 WO2015070746 A1 WO 2015070746A1 CN 2014090849 W CN2014090849 W CN 2014090849W WO 2015070746 A1 WO2015070746 A1 WO 2015070746A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- test strip
- quantum dot
- sample
- cds
- zns
- Prior art date
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 226
- 239000002096 quantum dot Substances 0.000 title claims abstract description 150
- 238000001514 detection method Methods 0.000 claims abstract description 94
- 238000003860 storage Methods 0.000 claims abstract description 44
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 claims description 50
- 239000012528 membrane Substances 0.000 claims description 30
- 238000004458 analytical method Methods 0.000 claims description 26
- 229910000673 Indium arsenide Inorganic materials 0.000 claims description 20
- RPQDHPTXJYYUPQ-UHFFFAOYSA-N indium arsenide Chemical compound [In]#[As] RPQDHPTXJYYUPQ-UHFFFAOYSA-N 0.000 claims description 20
- 229910004613 CdTe Inorganic materials 0.000 claims description 15
- 229910004262 HgTe Inorganic materials 0.000 claims description 15
- SBIBMFFZSBJNJF-UHFFFAOYSA-N selenium;zinc Chemical compound [Se]=[Zn] SBIBMFFZSBJNJF-UHFFFAOYSA-N 0.000 claims description 15
- 239000012491 analyte Substances 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 239000000020 Nitrocellulose Substances 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 229920001220 nitrocellulos Polymers 0.000 claims description 10
- 239000004033 plastic Substances 0.000 claims description 10
- 229920000728 polyester Polymers 0.000 claims description 10
- 206010028980 Neoplasm Diseases 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- 239000002105 nanoparticle Substances 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 6
- YBNMDCCMCLUHBL-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-pyren-1-ylbutanoate Chemical compound C=1C=C(C2=C34)C=CC3=CC=CC4=CC=C2C=1CCCC(=O)ON1C(=O)CCC1=O YBNMDCCMCLUHBL-UHFFFAOYSA-N 0.000 claims description 5
- 229910015808 BaTe Inorganic materials 0.000 claims description 5
- 229910004813 CaTe Inorganic materials 0.000 claims description 5
- 229910017680 MgTe Inorganic materials 0.000 claims description 5
- 239000004677 Nylon Substances 0.000 claims description 5
- 229910018219 SeTe Inorganic materials 0.000 claims description 5
- 101100125839 Xenopus laevis inka1-a gene Proteins 0.000 claims description 5
- 229910007709 ZnTe Inorganic materials 0.000 claims description 5
- 239000002250 absorbent Substances 0.000 claims description 5
- 230000002745 absorbent Effects 0.000 claims description 5
- 229920002301 cellulose acetate Polymers 0.000 claims description 5
- 239000011258 core-shell material Substances 0.000 claims description 5
- 239000003365 glass fiber Substances 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 5
- 239000002114 nanocomposite Substances 0.000 claims description 5
- 229920001778 nylon Polymers 0.000 claims description 5
- FESBVLZDDCQLFY-UHFFFAOYSA-N sete Chemical compound [Te]=[Se] FESBVLZDDCQLFY-UHFFFAOYSA-N 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc oxide Inorganic materials [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 5
- 208000023275 Autoimmune disease Diseases 0.000 claims description 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 4
- 208000035473 Communicable disease Diseases 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000001124 body fluid Anatomy 0.000 claims description 4
- 239000010839 body fluid Substances 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 4
- 238000011109 contamination Methods 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 238000003255 drug test Methods 0.000 claims description 4
- 238000003912 environmental pollution Methods 0.000 claims description 4
- 239000005556 hormone Substances 0.000 claims description 4
- 229940088597 hormone Drugs 0.000 claims description 4
- 239000000447 pesticide residue Substances 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 230000028327 secretion Effects 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 238000002845 discoloration Methods 0.000 claims description 3
- 229960000074 biopharmaceutical Drugs 0.000 claims 1
- 210000004392 genitalia Anatomy 0.000 claims 1
- 238000003780 insertion Methods 0.000 abstract description 8
- 230000037431 insertion Effects 0.000 abstract description 8
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 83
- 238000000034 method Methods 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 239000004005 microsphere Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000012982 microporous membrane Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 208000017604 Hodgkin disease Diseases 0.000 description 3
- 239000003124 biologic agent Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 210000005000 reproductive tract Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 2
- 102000009840 Angiopoietins Human genes 0.000 description 2
- 108010009906 Angiopoietins Proteins 0.000 description 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- SPSSULHKWOKEEL-UHFFFAOYSA-N 2,4,6-trinitrotoluene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O SPSSULHKWOKEEL-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010049048 Cholera Toxin Proteins 0.000 description 1
- 102000009016 Cholera Toxin Human genes 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 101000867232 Escherichia coli Heat-stable enterotoxin II Proteins 0.000 description 1
- 101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- 108010079723 Shiga Toxin Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- -1 antibodies Proteins 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 230000036046 immunoreaction Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000003692 lymphatic flow Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Definitions
- the invention belongs to the field of in-vitro diagnosis, and particularly relates to a quantum dot mark capable of rapidly quantifying a single component or a multi-component concentration of a sample by combining an instrument with a test standard curve or a coefficient parameter and the like, and an instrument having a signal detection function.
- Test strip card
- GICA Gold-Immunochromatography Assay
- nano quantum dots have unique and excellent optical properties: high fluorescence efficiency, wide excitation line range, single-element excitation, multiple emission, narrow emission spectrum and symmetry, and slow photobleaching speed.
- the fluorescence lifetime is long, the particle size is similar to that of biomolecules, and the surface modification can be multi-functionalized.
- the characteristic wavelength fluorescence spectra produced by the mixture of quantum dots of different particle sizes and kinds do not overlap, which is very suitable for sample multi-component analysis. Sweeny et al.
- Goldman's group used multicolor quantum dots to simultaneously detect enterotoxin B and 2,4,6-trinitrotoluene produced by staphylococci and four toxins of cholera toxin, ricin, Shiga toxin and staphylococcal toxin.
- quantum dots are used as fluorescent labels in microfluidic protein chips, and their fluorescent pleochroism can simultaneously detect tumor markers carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) with detection limits as low as 250fmol. /L, 4 orders of magnitude higher than detection with organic fluorescent dyes.
- CEA carcinoembryonic antigen
- AFP alpha-fetoprotein
- VEGF A vascular endothelial growth factor A
- angiopoietin angiopoietin
- quantum dots of different emission wavelengths respectively, and causing aggregation of quantum dots by antigen-antibody specific binding reaction, using flow cytometry
- the characteristic fluorescent signal was quantitatively detected to obtain the concentration of the corresponding antigen, and the detection limit was 1 pmol/L, and simultaneous detection of various antigens was achieved.
- quantum dot coding to perform multi-component analysis. This technology is mainly encoded by the richness of quantum dot fluorescence color and fluorescence intensity. It can simultaneously measure more components and achieve simultaneous analysis of massive information in protein analysis, DNA analysis and drug screening. .
- n kinds of intensity m colors can generate n m -1 kinds of codes, and the detection and detection of n m -1 kinds of targets can be realized by decoding technology.
- the calculation only 50,000 to 40,000 identifiable nanoparticle-encoded microspheres can be obtained by combining 5 to 6 colors with 6 quantum dots of different luminescence intensity. If combined with 10 quantum-intensity quantum dot nanoparticles, one million identifiable nanoparticle-encoded microspheres can be obtained. These microspheres can theoretically encode 1 million different DNA or proteins. Simultaneous detection of 1 million different DNAs or proteins in a sample! Nie et al.
- Wilson and Cooper used this technology to achieve three serum proteins (chicken ovalbumin OVA, bovine serum albumin BSA, human serum albumin HAS) and four immunoglobulin G (human IgG, rabbit IgG, murine IgG, sheep). Simultaneous detection of IgG).
- Chinese Patent Application No. 200610024086.7 discloses a method for detecting a quantum dot-labeled rapid immunochromatographic test strip.
- the patent enables multi-component simultaneous detection, it is a method that is claimed, and no request for protection of a quantum dot-labeled rapid immunochromatographic test strip product has been proposed.
- this method has some shortcomings: (1) To achieve multi-component detection of samples, it is necessary to simultaneously set a plurality of corresponding detection lines on the analysis membrane, that is, each detection line is only used to detect one index in the sample, and the detection efficiency is low.
- the detector wants to simultaneously detect a large number of components, flux components, and even large components in the sample, it is impossible for a small test strip to achieve the detection target by setting such a large number of corresponding detection lines.
- Quantifying the concentration of the test substance using the standard curve of the test subject standard is the main method for quantifying the concentration of the sample in the field of detection.
- Recently developed storage media in the information field such as RFID tags (also known as radio frequency identification tags), IC chips, magnetic codes, barcodes, etc., for information access identification is now widely used in computers, communications, electronics, commerce, transportation Control management and other fields, especially RFID tags, small size, large storage information capacity, identification without manual intervention, is an ideal means of information access identification, but few people currently use it for biomedical testing.
- the present invention is directed to the deficiencies and shortcomings of the prior art, and provides a quantum dot marking strip card on which a storage medium 13 is mounted, the storage medium 13 storing the same batch of quantum dot marking strips 2 for quantitative detection of the sample.
- Information for testing such as standard curve or coefficient parameters for concentration.
- the characteristic signal of the test strip 2 in the test strip 2 is collected by the instrument having the signal detecting function, and the detected object is simultaneously read from the storage medium 13 in combination with the apparatus.
- the standard curve or coefficient parameters are calculated to obtain the one-component or multi-component concentration of the sample.
- the invention is characterized in that the sample concentration, in particular the multi-component concentration of the sample, is simple, rapid, sensitive, objective, and flexible.
- the quantum dot-labeled test strip card of the present invention comprises a cartridge 3 and a quantum dot marking strip 2.
- the quantum dot marking test strip 2 includes a sample pad 4, a marking pad 5, an analysis film 7, and an absorbent pad 8 which are sequentially attached to the substrate 1 by overlapping.
- the analysis membrane 7 has a detection strip 6.
- One end of the cartridge 3 and the upper opening of the cartridge end form a test strip slot 12 to facilitate insertion of the quantum dot marking strip 2 into the cartridge 3.
- the test strip 2 is a separate insertion structure of the cartridge 3. At the time of sample detection, the test strip 2 inserted into the cartridge 3 has one end of the sample pad 4 interfering with the open end of the cartridge 3 to be immersed to suck the sample.
- the upper casing of the cartridge 3 is provided with a detection window 11 at a position corresponding to the test strip analysis film 7.
- a storage medium 13 is mounted on the cartridge 3.
- the marking pad 5 of the quantum dot marking strip 2 is coated with a single specific molecule related to a target detection of a single quantum dot label, or: a target analyte coated with a label corresponding to a single quantum dot A mixture of related specific molecules is detected.
- the single quantum dots coated by the marking pad 5 include ZnS, CdS, HgS, ZnSe, CdSe, HgSe, CdTe, ZnTe, ZnO, PbSe, HgTe, CaAs, InP, InAs, InCaAs, CdS/ZnS, CdS/Ag 2 S, CdS/PbS, CdS/Cd(OH) 2 , CdS/HgS, CdS/HgS/CdS, ZnS/CdS, ZnS/CdS/ZnS, ZnS/HgS/ZnS/CdS, CdSe/CdS, CdSe/ZnS, CdSe/ZnSe, CdSe/CuSe, CdSe/HgTe, CdSe/HgSe, CdSe/HgSe/CdSe, CdTe/HgS, C
- the detection band 6 of the quantum dot marking strip 2 may be one piece or a plurality of pieces.
- the test strip 6 is coated with another specific molecule associated with detection of a target analyte, or a mixture of another specific molecule coated with detection of each target analyte.
- the storage medium 13 includes, but is not limited to, an RFID tag, an IC chip, a magnetic code, or a barcode.
- the storage medium 13 stores the standard curve or coefficient parameter of the sample for quantitative sample concentration of the same batch of quantum dot labeling strip 2, the test strip batch number, the strip validity period, the storage medium password, the clinical index reference value, and the test strip. Manufacturer information, etc., and can read information such as the identity information of the object to be tested, the information of the detector, the name of the sample, the sample number, the date of detection, and the test result.
- the standard curve of the test object stored in the storage medium 13 can be selected in various forms, including but not limited to the corresponding relationship between the concentration of the sample standard series and the OD detection zone .
- the OD detection zone is defined as the detection band optical density value measured by the concentration of the sample standard series.
- a test strip reaction end point indicating label 9 can be overlapped.
- the test strip reaction end point of the cartridge 3 indicates that the label 9 has a viewing window 11 corresponding thereto.
- the strip reaction end point indicating label 9 includes a pH test strip having a discoloration range of 5-9.
- the marking pad 5 of the quantum dot marking strip 2 of the present invention is a glass fiber membrane; the analysis membrane 7 of the quantum dot marking strip 2 is a nitrocellulose membrane, a nylon membrane, or a nitrocellulose/cellulose acetate mixed membrane.
- the underlayer 1 of the quantum dot marking strip 2 is a polyester or plastic plate; the cartridge 3 is made of polyester, plastic, hard paper material, or other material.
- the quantum dot marking test strip 2 of the present invention is a disposable product, and the storage medium 13 on the cartridge 3 and the cartridge 3 is a used product matched with the same batch of quantum dot marking test strips 2.
- the quantum dot marking strip card of the present invention When the quantum dot marking strip card of the present invention is used for sample detection, the quantum dot marking strip 2 is currently inserted into the cartridge 3, and the interference protruding end of the strip 2 inserted into the cartridge 3 is immersed in the liquid. sample. After the liquid sample is subjected to the test strip reaction on the test strip 2, the characteristic signal of the strip 2 is collected by the instrument having the signal detecting function (such as a reading instrument, a fluorescence detector, etc.) and combined with the instrument to store the strip from the strip. The storage medium 13 simultaneously reads the sample standard curve or coefficient parameter to calculate the single component or multi-component concentration of the sample.
- the instrument having the signal detecting function such as a reading instrument, a fluorescence detector, etc.
- the sample to be tested of the quantum dot-labeled test strip card of the present invention may be from clinical or non-clinical blood, body fluid, urine, saliva, genital tract secretion or other liquid sample or viscous sample, wherein the clinical sample includes Samples of infectious diseases, hormones, cardiovascular diseases, tumors, cancer, diabetes, autoimmune diseases, etc., non-clinical samples including food testing, environmental pollution testing, pesticide residue testing, biological contamination testing, biological agent testing, veterinary medicine Samples such as testing, drug testing, etc.
- the present invention has the following beneficial effects:
- the test strip card combined with the instrument with signal detection function can realize synchronous multi-component rapid quantitative detection (including qualitative detection).
- Quantum dots of different particle sizes, types and structures can produce continuous fluorescence with different characteristic wavelengths, and the characteristic wavelength fluorescence peak spectra generated by the quantum dot mixture do not overlap.
- the present invention uses different quantum dots to respectively mark the corresponding reaction molecules of the analyte, and mixes the same. The coating is reacted with the sample to be tested on the test strip 2 of the test strip card, and the characteristic fluorescent signal of the test strip 2 is measured, thereby enabling rapid quantification of the multi-component concentration of the sample.
- the time for testing the sample is short, and the result can be obtained in a few minutes.
- the quantitative sample concentration of the present invention requires the operator to prepare a standard curve of the test object, and the test information such as the standard curve or the coefficient parameter of the test object is stored on the storage medium 13.
- the operator only needs to put the test strip to which the sample is applied to be completed after the test strip reaction, and then put the instrument with the signal detection function, and the instrument collects the characteristic fluorescent signal of the strip 2 of the test strip 2, and combines the
- the standard test curve or coefficient parameter of the corresponding test object read from the storage medium 13 can quantitatively obtain the sample test result in a few minutes.
- the amount of sample is small, and a few microliters to several tens of microliters can meet the detection needs.
- the reagents and materials in the test strip are not involved in activity inactivation and can be stored at room temperature for a long time.
- Figure 1 is a top plan view of a preferred embodiment of the quantum dot-labeled test strip card of the present invention (in which a test strip is used as a test line)
- Figure 2 The preferred embodiment of the quantum dot-labeled test strip card of the present invention is a side view of the inserted test strip (the test strip uses a test line)
- Figure 3 is a top plan view of a preferred embodiment of the quantum dot-labeled test strip card of the present invention (in which a plurality of test lines are used for inserting test strips)
- Figure 4 is a side view structural view of a preferred embodiment of the quantum dot-labeled test strip card of the present invention, which is a matching test strip (the test strip uses a plurality of test lines)
- Figure 5 is a top plan view of another preferred embodiment of the quantum dot-labeled test strip card of the present invention (in which a plug-in test strip adopts a test line)
- Figure 6 is a side view structural view of a plug-in test strip of another preferred embodiment of the quantum dot-labeled test strip card of the present invention (the test strip adopts a test line)
- Figure 7 is a top plan view of another preferred embodiment of the quantum dot-labeled test strip card of the present invention (in which a plurality of test lines are used for inserting test strips)
- Figure 8 is a side view structural view of a plug-in test strip of another preferred embodiment of the quantum dot-labeled test strip card of the present invention (the test strip uses a plurality of test lines)
- Embodiment 1 is one of the preferred embodiments of the quantum dot marking strip card of the present invention.
- the quantum dot marking strip card of the preferred embodiment comprises a cartridge 3 and a quantum dot marking strip 2.
- the quantum dot marking test strip 2 includes a sample pad 4, a marking pad 5, an analysis film 7, and an absorbent pad 8 which are sequentially attached to the substrate 1 by overlapping.
- the analysis membrane 7 has a detection strip 6.
- One end of the cartridge 3 and the upper opening of the cartridge end form a test strip slot 12 to facilitate insertion of the quantum dot marking strip 2 into the cartridge 3.
- the test strip 2 is a separate insertion structure of the cartridge 3.
- the test strip 2 inserted into the cartridge 3 has one end of the sample pad 4 interfering with the open end of the cartridge 3 to be immersed to suck the sample.
- the upper casing of the cartridge 3 is provided with a detection window 10 at a position corresponding to the test strip analysis film 7.
- a storage medium 13 is mounted on the cartridge 3.
- the marking pad 5 of the quantum dot marking strip 2 is coated with a single specific molecule related to a target detection of a single quantum dot label, or: a target analyte coated with a label corresponding to a single quantum dot A mixture of related specific molecules is detected.
- the single quantum dot of the test strip 2 marking pad 5 may be selected from the group consisting of ZnS, CdS, HgS, ZnSe, CdSe, HgSe, CdTe, ZnTe, ZnO, PbSe, HgTe, CaAs, InP, InAs, InCaAs, CdS/ ZnS, CdS/Ag 2 S, CdS/PbS, CdS/Cd(OH) 2 , CdS/HgS, CdS/HgS/CdS, ZnS/CdS, ZnS/CdS/ZnS, ZnS/HgS/ZnS/CdS, CdSe/ CdS, CdSe/ZnS, CdSe/ZnSe, CdSe/CuSe, CdSe/HgTe, CdSe/HgSe, CdSe/HgSe/CdSe
- the detection strip 6 of the quantum dot marking strip 2 may be one (shown in FIGS. 1 and 2) or a plurality of strips (shown in FIGS. 3 and 4).
- the test strip 6 is coated with another specific molecule associated with detection of a target analyte, or a mixture of another specific molecule coated with detection of each target analyte.
- the storage medium 13 includes, but is not limited to, an RFID tag, an IC chip, a magnetic code, or a barcode.
- the standard curve or coefficient parameter of the test object, the test strip batch number, the test strip validity period, the storage medium password, the clinical index reference value, and the test strip manufacturer information are stored in the same batch of quantum dot labeling strip 2 quantitative sample concentration. Etc., and can read information such as the identity information of the object to be tested, the information of the detector, the name of the sample, the sample number, the date of detection, and the test result.
- the standard curve of the test object stored in the storage medium 13 can be selected in various forms, including but not limited to the corresponding relationship between the concentration of the sample standard series and the OD detection zone .
- the OD detection zone is defined as the detection band optical density value measured by the concentration of the sample standard series.
- the marking pad 5 of the quantum dot marking strip 2 is a glass fiber membrane;
- the analysis membrane 7 of the quantum dot marking strip 2 is a nitrocellulose membrane, a nylon membrane, or a nitrocellulose/cellulose acetate mixed membrane;
- the underlayer 1 of the quantum dot marking strip 2 is a polyester or plastic plate;
- the cartridge 3 is made of polyester, plastic, hard paper material, or other material.
- the quantum dot marking strip 2 is a disposable product, and the storage medium 13 on the cartridge 3 and the cartridge 3 is a used product matched with the same batch of quantum dot marking strips 2.
- the quantum dot marking test strip card When the quantum dot marking test strip card is used for sample detection, the quantum dot marking test strip 2 is currently inserted into the cartridge 3, and the liquid protruding sample is immersed in the interference protruding end of the test strip 2 inserted into the cartridge 3 to suck the liquid sample.
- the characteristic signal of the strip 2 After the liquid sample is subjected to the test strip reaction on the test strip 2, the characteristic signal of the strip 2 is collected by the instrument having the signal detecting function (such as a reading instrument, a fluorescence detector, etc.) and combined with the instrument to store the strip from the strip.
- the storage medium 13 simultaneously reads the standard curve or coefficient parameter of the test object and calculates the sample. Single or multi-component concentration.
- the sample to be tested of the quantum dot-labeled test strip card may be from clinical or non-clinical blood, body fluid, urine, saliva, genital tract secretion or other liquid sample or viscous sample, wherein the clinical sample includes infectious diseases Samples such as hormones, cardiovascular diseases, tumors, cancer, diabetes, autoimmune diseases, etc.
- infectious diseases Samples such as hormones, cardiovascular diseases, tumors, cancer, diabetes, autoimmune diseases, etc.
- Non-clinical samples include food testing, environmental pollution testing, pesticide residue testing, biological contamination testing, biological agent testing, veterinary testing, Samples such as drug testing.
- Embodiment 2 is another preferred embodiment of the quantum dot marking strip card of the present invention.
- the quantum dot marking strip card of the preferred embodiment comprises a cartridge 3 and a quantum dot marking strip 2.
- the quantum dot marking strip 2 includes a sample pad 4, a marker pad 5, an analysis film 7, an absorbent pad 8 and a test strip reaction end indicating label 9 which are sequentially attached to the substrate 1.
- the analysis membrane 7 has a detection strip 6.
- One end of the cartridge 3 and the upper opening of the cartridge end form a test strip slot 12 to facilitate insertion of the quantum dot marking strip 2 into the cartridge 3.
- the test strip 2 is a separate insertion structure of the cartridge 3. At the time of sample detection, the test strip 2 inserted into the cartridge 3 has one end of the sample pad 4 interfering with the open end of the cartridge 3 to be immersed to suck the sample.
- the upper casing of the cartridge 3 is provided with a detection window 10 at a position corresponding to the test strip analysis film 7, and the upper casing of the cartridge 3 is provided with an observation window 11 at a position corresponding to the test strip end point indicating label 9, the cartridge A storage medium 13 is mounted on the third.
- the marking pad 5 of the quantum dot marking strip 2 is coated with a single specific molecule related to a target detection of a single quantum dot label, or: a target analyte coated with a label corresponding to a single quantum dot A mixture of related specific molecules is detected.
- the single quantum dot of the strip mark pad 5 may be selected from the group consisting of ZnS, CdS, HgS, ZnSe, CdSe, HgSe, CdTe, ZnTe, ZnO, PbSe, HgTe, CaAs, InP, InAs, InCaAs, CdS/ZnS.
- the detection strip 6 of the quantum dot marking strip 2 may be one (shown in FIGS. 5 and 6) or a plurality of strips (shown in FIGS. 7 and 8).
- the test strip 6 is coated with another specific molecule associated with detection of a target analyte, or a mixture of another specific molecule coated with detection of each target analyte.
- the strip reaction end point indicating label 9 includes a pH test strip having a discoloration range of 5-9.
- the test strip reaction end point label 9 on the test strip can be colored according to the pH condition of the test strip reaction, to indicate whether the test strip reactant has fully oozing through the test strip 6, indicating whether the test strip reaction is sufficient, Whether the test result is valid.
- the storage medium 13 includes, but is not limited to, an RFID tag, an IC chip, a magnetic code, or a barcode.
- the standard curve or coefficient parameter of the test object, the test strip batch number, the test strip validity period, the storage medium password, the clinical index reference value, and the test strip manufacturer information are stored in the same batch of quantum dot labeling strip 2 quantitative sample concentration. Etc., and can read information such as the identity information of the object to be tested, the information of the detector, the name of the sample, the sample number, the date of detection, and the test result.
- the standard curve of the test object stored in the storage medium 13 can be selected in various forms, including but not limited to the corresponding relationship between the concentration of the sample standard series and the OD detection zone .
- the OD detection zone is defined as the detection band optical density value measured by the concentration of the sample standard series.
- the marking pad 5 of the quantum dot marking strip 2 is a glass fiber membrane;
- the analysis membrane 7 of the quantum dot marking strip 2 is a nitrocellulose membrane, a nylon membrane, or a nitrocellulose/cellulose acetate mixed membrane;
- the bottom liner 1 of the quantum dot marking strip 2 is a polyester or plastic plate;
- the cartridge 3 is polyester, plastic, rigid Made of paper materials or other materials.
- the quantum dot marking strip 2 is a disposable product.
- the storage medium 13 on the cartridge 3 and the cartridge 3 is used for the same batch of quantum dot marking strips 2.
- the quantum dot marking test strip card When the quantum dot marking test strip card is used for sample detection, the quantum dot marking test strip 2 is currently inserted into the cartridge 3, and the liquid protruding sample is immersed in the interference protruding end of the test strip 2 inserted into the cartridge 3 to suck the liquid sample.
- Test strip reaction end point indication label 9 color display indicator After the strip test is completed on the test strip 2, the characteristic signal of the test strip 2 is detected by the instrument having the signal detection function (such as a reading instrument, a fluorescence detector, etc.) The single component or multi-component concentration of the sample is calculated by combining the standard curve or coefficient parameter of the sample simultaneously read from the test strip storage medium 13 by the instrument.
- the sample to be tested of the quantum dot-labeled test strip card may be from clinical or non-clinical blood, body fluid, urine, saliva, genital tract secretion or other liquid sample or viscous sample, wherein the clinical sample includes infectious diseases Samples such as hormones, cardiovascular diseases, tumors, cancer, diabetes, autoimmune diseases, etc.
- infectious diseases Samples such as hormones, cardiovascular diseases, tumors, cancer, diabetes, autoimmune diseases, etc.
- Non-clinical samples include food testing, environmental pollution testing, pesticide residue testing, biological contamination testing, biological agent testing, veterinary testing, Samples such as drug testing.
- the quantum dot-labeled test strip card of the present invention may have other improvements, such as a storage medium 13 storing detection information such as a test sample standard curve, in addition to the cartridge 3 mounted on the test strip card. Above and outside, it can also be directly mounted on the quantum dot marking strip 2; based on the same principle of the invention, the quantum dot marking strip inserted into the cartridge 3 can also be extended to replace the quantum dot labeled biochip (including antigenic antibodies). Chips, protein chips, nucleic acid chips, microfluidic chips, etc. Therefore, any other technical solution formed by any equivalent replacement or equivalent transformation of the quantum dot-labeled test strip card of the present invention falls within the scope of protection of the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Nanotechnology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
A test strip card marked by quantum dots, comprising a card case (3) and a quantum dot marked test strip (2); a test strip insertion slot (12) is formed in the opening at one end of the card case (3); the test strip (2) is a detached insertion structure of the card case (3); the card case (3) has a storage medium (13) thereon stored with the standard curve information of a sample object to be tested; when conducting sample testing, one end of the sample absorption pad (4) of a test strip (2) inserted in the card case (3) extends out of the opening end of the card case (3) to dip into and absorb the sample, and an instrument having a signal detection function collects the characteristic signal of a detection band (6) of the test strip (2), and combines the standard curve or coefficient parameter of the object to be tested simultaneously read from the storage medium (13) so as to calculate and obtain the single-component or multicomponent concentration of the sample. The present invention is convenient and fast, and flexible to use, and is highly sensitive and produces objective results.
Description
本发明属于体外诊断领域,具体涉及一种自身带有被检物标准曲线或系数参数等检测用信息、结合具有信号检测功能的仪器能快速定量样品单一组分或多组分浓度的量子点标记的试条卡。The invention belongs to the field of in-vitro diagnosis, and particularly relates to a quantum dot mark capable of rapidly quantifying a single component or a multi-component concentration of a sample by combining an instrument with a test standard curve or a coefficient parameter and the like, and an instrument having a signal detection function. Test strip card.
胶体金免疫层析技术(Gold-Immunochromatography Assay,GICA)现已广泛应用于免疫检测的各个方面,其以微孔滤膜为载体,利用微孔滤膜的毛细管作用,使滴加在膜条一端的液体样品慢慢向微孔滤膜另一端渗移,若液体中有特异抗原或抗体,它们可以和免疫金结合后再与包被在微孔滤膜上的相应抗体或抗原结合而显示免疫金颜色(红色)。该技术简单快速,几分钟就能用肉眼观察结果。不足之处是:(1)只能定性检测样品,难能实现样品定量。(2)难能做到样品多组分同时检测,检测效率低。(3)对于某些抗原或抗体含量极低的样本,胶体金颜色很浅很难用肉眼判断结果,检测灵敏度低。Gold-Immunochromatography Assay (GICA) has been widely used in all aspects of immunoassay. It uses a microporous membrane as a carrier and uses capillary action of a microporous membrane to make it drop on one end of the membrane strip. The liquid sample slowly migrates to the other end of the microporous membrane. If there is a specific antigen or antibody in the liquid, they can bind to the immunogold and then bind to the corresponding antibody or antigen coated on the microporous membrane to display immunity. Gold color (red). The technique is simple and fast, and the results can be observed with the naked eye in a matter of minutes. The shortcomings are: (1) It is only possible to qualitatively test the sample, and it is difficult to quantify the sample. (2) It is difficult to simultaneously test multiple components of the sample, and the detection efficiency is low. (3) For samples with very low antigen or antibody content, the colloidal gold color is very light and difficult to judge with the naked eye, and the detection sensitivity is low.
实现样品多组分快速定量检测,一直是人们长期追求的目标。近年发展的纳米量子点(quantum dots,QDs),具有独特优良光学性质:荧光发光效率高,激发谱线范围宽,能一元激发,多元发射,发射谱线范围窄且对称,光漂白速度慢,荧光寿命长,粒径与生物分子相近,表面修饰后能多功能化,不同粒径和种类的量子点混合物产生的特征波长荧光光谱不交叠,非常适于样品多组分分析。Sweeny等将三种一抗分别与三种不同发射波长的量子点(605nm和655nm)通过生物素-亲和素的特异性结合形成抗体-量子点复合物,通过荧光成像实现了扁桃体中3种不同抗体的同时分析,证明应用多色量子点可在同一样品中同时定位多种生物标志物。Nie等用4种不同发射波长的量子点标记4种抗体实现了对霍奇金淋巴瘤中病理标志性细胞HRS(Hodgkin’s and Reed-Sternberg)的成像检测,提高了检测灵敏度和特异性,有利于临床快速准确地诊断霍奇金淋巴瘤。Kobayashi等和Chan等分别用两种不同颜色的近红外量子点成像分析小鼠的淋巴管流路和左右胸腔,证明了近红外量子点的多重成像分析作用。利用量子点的荧光特性除了进行成像分析外还可以实现对多种病原体、毒素、抗原、抗体、酶、小分子物质以及离子等的定性定量分析。Zahavy等制备荧光探针和结合流式细胞仪实现了两种致病菌的同时定量检测,检测限可达到103cfu/mL。Goldman课题组用多色量子点实现了葡萄球菌产生的肠毒素B和2,4,6-三硝基甲苯以及霍乱毒素、蓖麻毒素、志贺毒素和葡萄球菌毒素四种毒素的同时检测。除此之外,在微流体蛋白质芯片中用量子点作荧光标记,利用其荧光多色性能够同时快速检测肿瘤标志物癌胚抗原(CEA)和甲胎蛋白(AFP),检测限低至250fmol/L,比用有机荧光染料检测高4个数量级。Giorgio等将血管内皮生长因子A(VEGF A)和血管生成素(angiopoietin)分别与不同发射波长的量子点构成荧光探针,通过抗原抗体特异性结合反应引起量子点的聚集,用流式细胞仪定量检测特征荧光信号从而得到相应抗原的浓度,检测限为1pmol/L,实现了多种抗原的同时检测。近些年来,不少研究者利用量子点编码的方法进行多组分分析。这一技术主要是借助量子点荧光颜色和荧光强度的丰富性进行编码,能够同时测定更多的组分,可实现对蛋白质分析、DNA分析及药物筛选等研究中所蕴藏的海量信
息的同步分析。理论上,n种强度m种颜色能够产生nm-1种代码,利用解码技术可以实现对nm-1种目标物的分析检测。根据计算,只需用5~6种颜色与6种不同发光强度的量子点纳米粒子进行组合,就能得到10000~40000个可识别的纳米粒子编码微球。如果与10种不同发光强度的量子点纳米粒子进行组合,则能得到100万个可识别的纳米粒子编码微球,这些微球理论上可以对100万个不同的DNA或蛋白质进行编码标记,从而实现对样品中的100万个不同的DNA或蛋白质进行同时检测!Nie等将红、绿、蓝三种不同颜色的量子点以1:1:1、1:2:1、2:1:1的比例包裹入聚苯乙烯微球进行编码,通过所得荧光光谱的不同特性实现了三种目标DNA的同时检测。采用类似技术,Gu和Sha等将两种不同发射波长的量子点以三种强度分别对DNA敏感型的水凝胶和微球进行编码分别实现了多种不同序列的单链DNA的定量检测和多种寡核苷酸的高通量筛选分型。Wilson和Cooper等分别利用此技术实现了三种血清蛋白(鸡卵白蛋白OVA、牛血清白蛋白BSA、人血清白蛋白HAS)以及四种免疫球蛋白G(人IgG、兔IgG、鼠IgG、羊IgG)的同时检测。It has been a long-term goal for the rapid quantitative detection of multi-component samples. In recent years, nano quantum dots (QDs) have unique and excellent optical properties: high fluorescence efficiency, wide excitation line range, single-element excitation, multiple emission, narrow emission spectrum and symmetry, and slow photobleaching speed. The fluorescence lifetime is long, the particle size is similar to that of biomolecules, and the surface modification can be multi-functionalized. The characteristic wavelength fluorescence spectra produced by the mixture of quantum dots of different particle sizes and kinds do not overlap, which is very suitable for sample multi-component analysis. Sweeny et al. used three primary antibodies with quantum dots of three different emission wavelengths ( 605nm and 655nm) form an antibody-quantum dot complex by specific binding of biotin-avidin, and simultaneous analysis of three different antibodies in the tonsil by fluorescence imaging, which proves that the application of multicolor quantum dots can be simultaneously in the same sample. Position multiple biomarkers. Nie et al. used four kinds of different wavelengths of quantum dots to label four kinds of antibodies to achieve imaging detection of Hodgkin's and Reed-Sternberg in Hodgkin's lymphoma, which improved detection sensitivity and specificity. Rapid and accurate diagnosis of Hodgkin's lymphoma. Kobayashi et al. and Chan et al. used two different color near-infrared quantum dot images to analyze the lymphatic flow and left and right thoracic cavity of mice, respectively, demonstrating the multiple imaging analysis of near-infrared quantum dots. In addition to image analysis, qualitative and quantitative analysis of various pathogens, toxins, antigens, antibodies, enzymes, small molecules, and ions can be performed by using the fluorescence characteristics of quantum dots. Zahavy et al. Preparation of fluorescent probes with Simultaneous quantitative detection of two pathogenic bacteria was achieved by flow cytometry, and the detection limit was 10 3 cfu/mL. Goldman's group used multicolor quantum dots to simultaneously detect enterotoxin B and 2,4,6-trinitrotoluene produced by staphylococci and four toxins of cholera toxin, ricin, Shiga toxin and staphylococcal toxin. In addition, quantum dots are used as fluorescent labels in microfluidic protein chips, and their fluorescent pleochroism can simultaneously detect tumor markers carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) with detection limits as low as 250fmol. /L, 4 orders of magnitude higher than detection with organic fluorescent dyes. Giorgio et al. constituting a fluorescent probe with vascular endothelial growth factor A (VEGF A) and angiopoietin (angiopoietin) and quantum dots of different emission wavelengths respectively, and causing aggregation of quantum dots by antigen-antibody specific binding reaction, using flow cytometry The characteristic fluorescent signal was quantitatively detected to obtain the concentration of the corresponding antigen, and the detection limit was 1 pmol/L, and simultaneous detection of various antigens was achieved. In recent years, many researchers have used quantum dot coding to perform multi-component analysis. This technology is mainly encoded by the richness of quantum dot fluorescence color and fluorescence intensity. It can simultaneously measure more components and achieve simultaneous analysis of massive information in protein analysis, DNA analysis and drug screening. . In theory, n kinds of intensity m colors can generate n m -1 kinds of codes, and the detection and detection of n m -1 kinds of targets can be realized by decoding technology. According to the calculation, only 50,000 to 40,000 identifiable nanoparticle-encoded microspheres can be obtained by combining 5 to 6 colors with 6 quantum dots of different luminescence intensity. If combined with 10 quantum-intensity quantum dot nanoparticles, one million identifiable nanoparticle-encoded microspheres can be obtained. These microspheres can theoretically encode 1 million different DNA or proteins. Simultaneous detection of 1 million different DNAs or proteins in a sample! Nie et al. encapsulated three different color quantum dots of red, green and blue into a polystyrene microsphere at a ratio of 1:1:1, 1:2:1, and 2:1:1 to encode the obtained fluorescence spectrum. Different characteristics enable simultaneous detection of three target DNAs. Using similar techniques, Gu and Sha et al. quantified single-stranded DNA with multiple different sequences by encoding two different wavelengths of quantum dots with three intensities to encode DNA-sensitive hydrogels and microspheres, respectively. High throughput screening typing of multiple oligonucleotides. Wilson and Cooper used this technology to achieve three serum proteins (chicken ovalbumin OVA, bovine serum albumin BSA, human serum albumin HAS) and four immunoglobulin G (human IgG, rabbit IgG, murine IgG, sheep). Simultaneous detection of IgG).
中国申请号专利200410010736.3,用胶体金标记抗体与目标物结合,通过免疫反应与膜上包被量子点标记的抗体结合,形成检测带,在用肉眼对检测带进行初步定性或半定量检测的基础上,再利用胶体金对荧光纳米粒子的荧光淬灭作用,通过检测荧光信号的淬灭程度对检测条带进行定量检测。该专利要用两种粒子标记,方法不够简单;采用荧光信号的淬灭程度进行定量检测,干扰因素多,检测灵敏度低。Chinese application number patent 200410010736.3, using colloidal gold labeled antibody to bind to the target, and binding to the quantum dot-labeled antibody on the membrane by immunoreaction to form a detection zone, which is based on the preliminary qualitative or semi-quantitative detection of the detection zone by the naked eye. On the top, the fluorescence quenching effect of the colloidal gold on the fluorescent nanoparticles is utilized, and the detection band is quantitatively detected by detecting the quenching degree of the fluorescent signal. The patent uses two kinds of particle labeling, and the method is not simple enough; the quantification degree of the fluorescent signal is used for quantitative detection, the interference factor is large, and the detection sensitivity is low.
中国申请号专利200610024086.7披露了一种量子点标记快速免疫层析试纸条的检测方法。该专利虽能实现多组分同时检测,但请求保护的是一种方法,没有提出请求保护基于量子点标记快速免疫层析试纸条产品。而且,该方法存在不足:(1)实现样品多组分检测需要在分析膜上同时设置多条相应的检测线,即每条检测线只用于检测样品中的一种指标,检测效率低。如果检测者想要同步检测样品中大量组分、通量组分、甚至海量组分,一个小小试条不可能通过设置如此众多相应的检测线来实现检测目标。(2)采用紫外灯照射试纸条以观察其荧光线有无或者强弱从而判断样品中是否含有目标物,真正意义上说,此仍是一种定性检测,或者至多只能达到对某种被检物的最低可检限测定,不能从根本上实现样品中任意组分的准确浓度检测,灵敏度仍低。Chinese Patent Application No. 200610024086.7 discloses a method for detecting a quantum dot-labeled rapid immunochromatographic test strip. Although the patent enables multi-component simultaneous detection, it is a method that is claimed, and no request for protection of a quantum dot-labeled rapid immunochromatographic test strip product has been proposed. Moreover, this method has some shortcomings: (1) To achieve multi-component detection of samples, it is necessary to simultaneously set a plurality of corresponding detection lines on the analysis membrane, that is, each detection line is only used to detect one index in the sample, and the detection efficiency is low. If the detector wants to simultaneously detect a large number of components, flux components, and even large components in the sample, it is impossible for a small test strip to achieve the detection target by setting such a large number of corresponding detection lines. (2) Using a UV lamp to illuminate the test strip to observe the presence or absence of the fluorescent line or to determine whether the sample contains the target. In the true sense, this is still a qualitative test, or at most it can only reach a certain The minimum detectable limit of the test object cannot fundamentally achieve accurate concentration detection of any component in the sample, and the sensitivity is still low.
采用被检物标准品标准曲线定量被检物浓度,是检测领域定量样品浓度的主要方法。信息领域近来发展的存贮介质,如RFID标签(又称射频识别标签)、IC芯片、磁码、条码等,用于信息存取识别现已广泛用于计算机、通讯、电子、商业、交通运输控制管理等领域,其中,尤其是RFID标签,体积小,存储信息容量大,识别无须人工干预,更是信息存取识别的理想手段,但目前很少有人将其用于生物医学检测。Quantifying the concentration of the test substance using the standard curve of the test subject standard is the main method for quantifying the concentration of the sample in the field of detection. Recently developed storage media in the information field, such as RFID tags (also known as radio frequency identification tags), IC chips, magnetic codes, barcodes, etc., for information access identification is now widely used in computers, communications, electronics, commerce, transportation Control management and other fields, especially RFID tags, small size, large storage information capacity, identification without manual intervention, is an ideal means of information access identification, but few people currently use it for biomedical testing.
本发明针对现有技术的不足和缺陷,提供一种其上安装有存贮介质13的量子点标记试条卡,该存贮介质13储存有同批次量子点标记试条2定量被检物浓度用的标准曲线或系数参数等检测用信息。样品在试条2上完成试条反应后,由具有信号检测功能的仪器采集试条卡内试条2检测带6的特征信号并结合该仪器从存贮介质13同时读取来的被检物标准曲线或系数参数而计算获得样品单组分或多组分浓度。本发明用于定量样品浓度特别是样品多组分浓度具有简便快速、灵敏度高、结果客观、使用灵活等特点。The present invention is directed to the deficiencies and shortcomings of the prior art, and provides a quantum dot marking strip card on which a storage medium 13 is mounted, the storage medium 13 storing the same batch of quantum dot marking strips 2 for quantitative detection of the sample. Information for testing such as standard curve or coefficient parameters for concentration. After the sample is subjected to the test strip reaction on the test strip 2, the characteristic signal of the test strip 2 in the test strip 2 is collected by the instrument having the signal detecting function, and the detected object is simultaneously read from the storage medium 13 in combination with the apparatus. The standard curve or coefficient parameters are calculated to obtain the one-component or multi-component concentration of the sample. The invention is characterized in that the sample concentration, in particular the multi-component concentration of the sample, is simple, rapid, sensitive, objective, and flexible.
发明内容Summary of the invention
本发明技术方案如下:
The technical scheme of the present invention is as follows:
本发明所述的量子点标记的试条卡,包括卡盒3和量子点标记试条2。所述量子点标记试条2包括顺次搭接固定在底衬1上的吸样垫4、标记垫5、分析膜7、吸水垫8。分析膜7具有检测带6。卡盒3的一端连同该卡盒端的上盒面开口形成试条插槽口12,以方便量子点标记试条2能现时插入卡盒3内。试条2为卡盒3的离式即插结构。样品检测时,插放到卡盒3内的试条2其吸样垫4一端过盈伸出卡盒3的开口端以浸渍吸取样品。卡盒3的上盒面在对应于试条分析膜7位置处开有检测窗11。卡盒3上安装有一存贮介质13。The quantum dot-labeled test strip card of the present invention comprises a cartridge 3 and a quantum dot marking strip 2. The quantum dot marking test strip 2 includes a sample pad 4, a marking pad 5, an analysis film 7, and an absorbent pad 8 which are sequentially attached to the substrate 1 by overlapping. The analysis membrane 7 has a detection strip 6. One end of the cartridge 3 and the upper opening of the cartridge end form a test strip slot 12 to facilitate insertion of the quantum dot marking strip 2 into the cartridge 3. The test strip 2 is a separate insertion structure of the cartridge 3. At the time of sample detection, the test strip 2 inserted into the cartridge 3 has one end of the sample pad 4 interfering with the open end of the cartridge 3 to be immersed to suck the sample. The upper casing of the cartridge 3 is provided with a detection window 11 at a position corresponding to the test strip analysis film 7. A storage medium 13 is mounted on the cartridge 3.
所述量子点标记试条2的标记垫5包被有单一量子点标记的某一目标被检物检测相关的单一特异分子,或:包被有不同单一量子点对应标记的各目标被检物检测相关的特异分子的混合物。标记垫5包被的所述单一量子点包括ZnS、CdS、HgS、ZnSe、CdSe、HgSe、CdTe、ZnTe、ZnO、PbSe、HgTe、CaAs、InP、InAs、InCaAs、CdS/ZnS、CdS/Ag2S、CdS/PbS、CdS/Cd(OH)2、CdS/HgS、CdS/HgS/CdS、ZnS/CdS、ZnS/CdS/ZnS、ZnS/HgS/ZnS/CdS、CdSe/CdS、CdSe/ZnS、CdSe/ZnSe、CdSe/CuSe、CdSe/HgTe、CdSe/HgSe、CdSe/HgSe/CdSe、CdTe/HgS、CdTe/HgTe、InAs/InP、InAs/CdSe、InAs/ZnSe、MgS、MgSe、MgTe、CaS、CaSe、CaTe、SrS、SrSe、SeTe、BaS、BaSe、BaTe、CdS:Mn、ZnS:Mn、CdS:Cu、ZnS:Cu、CdS:Tb、ZnS:Tb中的任意一种或任意几种纳米粒子的组合,以及由上述任意一种量子点为核、二氧化硅为壳的核-壳型纳米复合粒子。The marking pad 5 of the quantum dot marking strip 2 is coated with a single specific molecule related to a target detection of a single quantum dot label, or: a target analyte coated with a label corresponding to a single quantum dot A mixture of related specific molecules is detected. The single quantum dots coated by the marking pad 5 include ZnS, CdS, HgS, ZnSe, CdSe, HgSe, CdTe, ZnTe, ZnO, PbSe, HgTe, CaAs, InP, InAs, InCaAs, CdS/ZnS, CdS/Ag 2 S, CdS/PbS, CdS/Cd(OH) 2 , CdS/HgS, CdS/HgS/CdS, ZnS/CdS, ZnS/CdS/ZnS, ZnS/HgS/ZnS/CdS, CdSe/CdS, CdSe/ZnS, CdSe/ZnSe, CdSe/CuSe, CdSe/HgTe, CdSe/HgSe, CdSe/HgSe/CdSe, CdTe/HgS, CdTe/HgTe, InAs/InP, InAs/CdSe, InAs/ZnSe, MgS, MgSe, MgTe, CaS, Any one or any of several kinds of nanoparticles of CaSe, CaTe, SrS, SrSe, SeTe, BaS, BaSe, BaTe, CdS: Mn, ZnS: Mn, CdS: Cu, ZnS: Cu, CdS: Tb, ZnS: Tb The combination, and the core-shell type nanocomposite particles in which any one of the above quantum dots is a core and silica is a shell.
所述量子点标记试条2的检测带6可以为一条,也可以为多条。检测带6包被有某一目标被检物检测相关的另一特异分子,或包被有各目标被检物检测相关的另一特异分子的混合物。The detection band 6 of the quantum dot marking strip 2 may be one piece or a plurality of pieces. The test strip 6 is coated with another specific molecule associated with detection of a target analyte, or a mixture of another specific molecule coated with detection of each target analyte.
所述存贮介质13包括但不限于RFID标签、IC芯片、磁码、或条码等。存贮介质13储存有同批次量子点标记试条2定量样品浓度用的被检物标准曲线或系数参数、试条批号、试条效期、存贮介质密码、临床指标参考值、试条生产厂商信息等,且可读入被测对象身份信息、检测者信息、样品名称、样品编号、检测日期、检测结果等信息。The storage medium 13 includes, but is not limited to, an RFID tag, an IC chip, a magnetic code, or a barcode. The storage medium 13 stores the standard curve or coefficient parameter of the sample for quantitative sample concentration of the same batch of quantum dot labeling strip 2, the test strip batch number, the strip validity period, the storage medium password, the clinical index reference value, and the test strip. Manufacturer information, etc., and can read information such as the identity information of the object to be tested, the information of the detector, the name of the sample, the sample number, the date of detection, and the test result.
所述存贮介质13储存的被检物标准曲线有多种形式可供选择,其包括但不限于被检物标准品系列浓度与OD检测带之间的对应关系曲线。所述OD检测带定义为被检物标准品系列浓度测得的检测带光密度值。The standard curve of the test object stored in the storage medium 13 can be selected in various forms, including but not limited to the corresponding relationship between the concentration of the sample standard series and the OD detection zone . The OD detection zone is defined as the detection band optical density value measured by the concentration of the sample standard series.
本发明所述量子点标记试条2的吸水垫8之后还可以搭接有一试条反应终点指示标签9。相应地,其卡盒3的该试条反应终点指示标签9对应处开有观察窗11。所述试条反应终点指示标签9包括变色范围为5-9的pH试纸。After the water absorbing pad 8 of the quantum dot marking test strip 2 of the present invention, a test strip reaction end point indicating label 9 can be overlapped. Correspondingly, the test strip reaction end point of the cartridge 3 indicates that the label 9 has a viewing window 11 corresponding thereto. The strip reaction end point indicating label 9 includes a pH test strip having a discoloration range of 5-9.
本发明所述量子点标记试条2的标记垫5为玻璃纤维膜;所述量子点标记试条2的分析膜7为硝酸纤维素膜、尼龙膜、或硝酸纤维素/醋酸纤维素混合膜;所述量子点标记试条2的底衬1为聚脂或塑料板;所述卡盒3为聚脂、塑料、硬性纸质材料、或其他材料做成。The marking pad 5 of the quantum dot marking strip 2 of the present invention is a glass fiber membrane; the analysis membrane 7 of the quantum dot marking strip 2 is a nitrocellulose membrane, a nylon membrane, or a nitrocellulose/cellulose acetate mixed membrane. The underlayer 1 of the quantum dot marking strip 2 is a polyester or plastic plate; the cartridge 3 is made of polyester, plastic, hard paper material, or other material.
本发明所述量子点标记试条2为一次性使用品,所述卡盒3及卡盒3上的存贮介质13为同批次量子点标记试条2配套的使用品。The quantum dot marking test strip 2 of the present invention is a disposable product, and the storage medium 13 on the cartridge 3 and the cartridge 3 is a used product matched with the same batch of quantum dot marking test strips 2.
本发明所述量子点标记试条卡用于样品检测时,其量子点标记试条2现时插入卡盒3内,插放到卡盒3内的试条2的过盈伸出端浸渍吸取液体样品。液体样品在试条2上完成试条反应后,由具有信号检测功能的仪器(如读条仪、荧光检测仪等)采集试条2检测带6的特征信号并结合该仪器从试条卡存贮介质13同时读取来的被检物标准曲线或系数参数而计算获得样品单组分或多组分浓度。
When the quantum dot marking strip card of the present invention is used for sample detection, the quantum dot marking strip 2 is currently inserted into the cartridge 3, and the interference protruding end of the strip 2 inserted into the cartridge 3 is immersed in the liquid. sample. After the liquid sample is subjected to the test strip reaction on the test strip 2, the characteristic signal of the strip 2 is collected by the instrument having the signal detecting function (such as a reading instrument, a fluorescence detector, etc.) and combined with the instrument to store the strip from the strip. The storage medium 13 simultaneously reads the sample standard curve or coefficient parameter to calculate the single component or multi-component concentration of the sample.
本发明所述量子点标记试条卡的待检样品可以是来自临床或非临床的血液、体液、尿液、唾液、生殖道分泌物或其他液态样品或粘稠状样品,其中,临床样品包括传染病、激素、心血管病、肿瘤、癌症、糖尿病、自身免疫病等在内的样品,非临床样品包括食品检测、环境污染检测、农药残留量检测、生物沾染检测、生物制剂检测、兽医学检测、毒品检测等在内的样品。The sample to be tested of the quantum dot-labeled test strip card of the present invention may be from clinical or non-clinical blood, body fluid, urine, saliva, genital tract secretion or other liquid sample or viscous sample, wherein the clinical sample includes Samples of infectious diseases, hormones, cardiovascular diseases, tumors, cancer, diabetes, autoimmune diseases, etc., non-clinical samples including food testing, environmental pollution testing, pesticide residue testing, biological contamination testing, biological agent testing, veterinary medicine Samples such as testing, drug testing, etc.
与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
(1)所述试条卡结合具有信号检测功能的仪器(如读条仪、荧光检测仪等)能实现样品多组分同步快速定量检测(包括定性检测)。不同粒径、种类和结构的量子点能产生不同特征波长持续荧光,量子点混合物产生的特征波长荧光峰谱不交叠,本发明采用不同量子点分别标记被检物相应反应分子,将其混合物包被在所述试条卡的试条2上与待测样品进行反应,通过测定试条2特征荧光信号,因而能快速定量样品多组分浓度。(1) The test strip card combined with the instrument with signal detection function (such as reading instrument, fluorescence detector, etc.) can realize synchronous multi-component rapid quantitative detection (including qualitative detection). Quantum dots of different particle sizes, types and structures can produce continuous fluorescence with different characteristic wavelengths, and the characteristic wavelength fluorescence peak spectra generated by the quantum dot mixture do not overlap. The present invention uses different quantum dots to respectively mark the corresponding reaction molecules of the analyte, and mixes the same. The coating is reacted with the sample to be tested on the test strip 2 of the test strip card, and the characteristic fluorescent signal of the test strip 2 is measured, thereby enabling rapid quantification of the multi-component concentration of the sample.
(2)检测样品时间短,几分钟就能获得结果。本发明定量样品浓度毋需操作者再制作被检物标准曲线,被检物的标准曲线或系数参数等检测用信息已备储存贮介质13上。样品检测时,操作者只需将施加有样品的试条卡待其完成试条反应后置入具有信号检测功能的仪器,由该仪器采集其试条2检测带6的特征荧光信号,结合该仪器从存贮介质13同时读取来的相应被检物标准曲线或系数参数,几分钟就能定量获得样品检测结果。(2) The time for testing the sample is short, and the result can be obtained in a few minutes. The quantitative sample concentration of the present invention requires the operator to prepare a standard curve of the test object, and the test information such as the standard curve or the coefficient parameter of the test object is stored on the storage medium 13. When the sample is tested, the operator only needs to put the test strip to which the sample is applied to be completed after the test strip reaction, and then put the instrument with the signal detection function, and the instrument collects the characteristic fluorescent signal of the strip 2 of the test strip 2, and combines the The standard test curve or coefficient parameter of the corresponding test object read from the storage medium 13 can quantitatively obtain the sample test result in a few minutes.
(3)样品用量少,几微升至几十微升就能满足检测需要。(3) The amount of sample is small, and a few microliters to several tens of microliters can meet the detection needs.
(4)试条卡内试剂和材料不涉及活性失活,可于室温长期保存。(4) The reagents and materials in the test strip are not involved in activity inactivation and can be stored at room temperature for a long time.
图l:本发明所述量子点标记试条卡优选方案一的俯视结构图(示其中即插试条采用一条检测线)Figure 1 is a top plan view of a preferred embodiment of the quantum dot-labeled test strip card of the present invention (in which a test strip is used as a test line)
图2:本发明所述量子点标记试条卡优选方案一相配套的即插试条的侧视结构图(示试条采用一条检测线)Figure 2: The preferred embodiment of the quantum dot-labeled test strip card of the present invention is a side view of the inserted test strip (the test strip uses a test line)
图3:本发明所述量子点标记试条卡优选方案一的俯视结构图(示其中即插试条采用多条检测线)Figure 3 is a top plan view of a preferred embodiment of the quantum dot-labeled test strip card of the present invention (in which a plurality of test lines are used for inserting test strips)
图4:本发明所述量子点标记试条卡优选方案一相配套的即插试条的侧视结构图(示试条采用多条检测线)Figure 4 is a side view structural view of a preferred embodiment of the quantum dot-labeled test strip card of the present invention, which is a matching test strip (the test strip uses a plurality of test lines)
图5:本发明所述量子点标记试条卡另一优选方案的俯视结构图(示其中即插试条采用一条检测线)Figure 5 is a top plan view of another preferred embodiment of the quantum dot-labeled test strip card of the present invention (in which a plug-in test strip adopts a test line)
图6:本发明所述量子点标记试条卡另一优选方案相配套的即插试条的侧视结构图(示试条采用一条检测线)Figure 6 is a side view structural view of a plug-in test strip of another preferred embodiment of the quantum dot-labeled test strip card of the present invention (the test strip adopts a test line)
图7:本发明所述量子点标记试条卡另一优选方案的俯视结构图(示其中即插试条采用多条检测线)Figure 7 is a top plan view of another preferred embodiment of the quantum dot-labeled test strip card of the present invention (in which a plurality of test lines are used for inserting test strips)
图8:本发明所述量子点标记试条卡另一优选方案相配套的即插试条的侧视结构图(示试条采用多条检测线)Figure 8 is a side view structural view of a plug-in test strip of another preferred embodiment of the quantum dot-labeled test strip card of the present invention (the test strip uses a plurality of test lines)
序号表示如下:The serial number is as follows:
1、底衬,2、试条,3、卡盒,4、吸样垫,5、标记垫,6、检测带,7、分析膜,8、吸水垫,9、试条反应终点指示标签,10、检测窗,11、观察窗,12、试条插槽口,13、存贮介质。1. Underlay, 2, test strip, 3, cartridge, 4, suction pad, 5, marker pad, 6, test tape, 7, analysis membrane, 8, absorbent pad, 9, test strip reaction end indication label, 10, detection window, 11, observation window, 12, test strip slot, 13, storage medium.
下面实施例及其附图仅是为了进一步说明本发明,本领域人员不应以此限制本发明的保护范围。The following examples and the accompanying drawings are only intended to further illustrate the invention, and those skilled in the art should not limit the scope of the invention.
实施例一 Embodiment 1
图1-4说明实施例一。实施例一为本发明所述量子点标记试条卡优选方案之一。Figures 1-4 illustrate a first embodiment. Embodiment 1 is one of the preferred embodiments of the quantum dot marking strip card of the present invention.
图1-4中,所述优选方案的所述量子点标记试条卡包括卡盒3和量子点标记试条2。所述量子点标记试条2包括顺次搭接固定在底衬1上的吸样垫4、标记垫5、分析膜7、吸水垫8。分析膜7具有检测带6。卡盒3的一端连同该卡盒端的上盒面开口形成试条插槽口12,以方便量子点标记试条2能现时插入卡盒3内。试条2为卡盒3的离式即插结构。样品检测时,插放到卡盒3内的试条2其吸样垫4一端过盈伸出卡盒3的开口端以浸渍吸取样品。卡盒3的上盒面在对应于试条分析膜7位置处开有检测窗10。卡盒3上安装有一存贮介质13。In Figures 1-4, the quantum dot marking strip card of the preferred embodiment comprises a cartridge 3 and a quantum dot marking strip 2. The quantum dot marking test strip 2 includes a sample pad 4, a marking pad 5, an analysis film 7, and an absorbent pad 8 which are sequentially attached to the substrate 1 by overlapping. The analysis membrane 7 has a detection strip 6. One end of the cartridge 3 and the upper opening of the cartridge end form a test strip slot 12 to facilitate insertion of the quantum dot marking strip 2 into the cartridge 3. The test strip 2 is a separate insertion structure of the cartridge 3. At the time of sample detection, the test strip 2 inserted into the cartridge 3 has one end of the sample pad 4 interfering with the open end of the cartridge 3 to be immersed to suck the sample. The upper casing of the cartridge 3 is provided with a detection window 10 at a position corresponding to the test strip analysis film 7. A storage medium 13 is mounted on the cartridge 3.
所述量子点标记试条2的标记垫5包被有单一量子点标记的某一目标被检物检测相关的单一特异分子,或:包被有不同单一量子点对应标记的各目标被检物检测相关的特异分子的混合物。试条2标记垫5的所述单一量子点可选用以下颗粒,包括ZnS、CdS、HgS、ZnSe、CdSe、HgSe、CdTe、ZnTe、ZnO、PbSe、HgTe、CaAs、InP、InAs、InCaAs、CdS/ZnS、CdS/Ag2S、CdS/PbS、CdS/Cd(OH)2、CdS/HgS、CdS/HgS/CdS、ZnS/CdS、ZnS/CdS/ZnS、ZnS/HgS/ZnS/CdS、CdSe/CdS、CdSe/ZnS、CdSe/ZnSe、CdSe/CuSe、CdSe/HgTe、CdSe/HgSe、CdSe/HgSe/CdSe、CdTe/HgS、CdTe/HgTe、InAs/InP、InAs/CdSe、InAs/ZnSe、MgS、MgSe、MgTe、CaS、CaSe、CaTe、SrS、SrSe、SeTe、BaS、BaSe、BaTe、CdS:Mn、ZnS:Mn、CdS:Cu、ZnS:Cu、CdS:Tb、ZnS:Tb中的任意一种或任意几种纳米粒子的组合,以及由上述任意一种量子点为核、二氧化硅为壳的核-壳型纳米复合粒子。The marking pad 5 of the quantum dot marking strip 2 is coated with a single specific molecule related to a target detection of a single quantum dot label, or: a target analyte coated with a label corresponding to a single quantum dot A mixture of related specific molecules is detected. The single quantum dot of the test strip 2 marking pad 5 may be selected from the group consisting of ZnS, CdS, HgS, ZnSe, CdSe, HgSe, CdTe, ZnTe, ZnO, PbSe, HgTe, CaAs, InP, InAs, InCaAs, CdS/ ZnS, CdS/Ag 2 S, CdS/PbS, CdS/Cd(OH) 2 , CdS/HgS, CdS/HgS/CdS, ZnS/CdS, ZnS/CdS/ZnS, ZnS/HgS/ZnS/CdS, CdSe/ CdS, CdSe/ZnS, CdSe/ZnSe, CdSe/CuSe, CdSe/HgTe, CdSe/HgSe, CdSe/HgSe/CdSe, CdTe/HgS, CdTe/HgTe, InAs/InP, InAs/CdSe, InAs/ZnSe, MgS, Any one of MgSe, MgTe, CaS, CaSe, CaTe, SrS, SrSe, SeTe, BaS, BaSe, BaTe, CdS: Mn, ZnS: Mn, CdS: Cu, ZnS: Cu, CdS: Tb, ZnS: Tb Or a combination of any of several kinds of nanoparticles, and a core-shell type nanocomposite particle in which any one of the above quantum dots is a core and silica is a shell.
所述量子点标记试条2的检测带6可以为一条(图1和图2所示),也可以为多条(图3和图4所示)。检测带6包被有某一目标被检物检测相关的另一特异分子,或:包被有各目标被检物检测相关的另一特异分子的混合物。The detection strip 6 of the quantum dot marking strip 2 may be one (shown in FIGS. 1 and 2) or a plurality of strips (shown in FIGS. 3 and 4). The test strip 6 is coated with another specific molecule associated with detection of a target analyte, or a mixture of another specific molecule coated with detection of each target analyte.
所述存贮介质13包括但不限于RFID标签、IC芯片、磁码、或条码等。其储存有同批次量子点标记试条2定量样品浓度用的被检物标准曲线或系数参数、试条批号、试条效期、存贮介质密码、临床指标参考值、试条生产厂商信息等,且可读入被测对象身份信息、检测者信息、样品名称、样品编号、检测日期、检测结果等信息。The storage medium 13 includes, but is not limited to, an RFID tag, an IC chip, a magnetic code, or a barcode. The standard curve or coefficient parameter of the test object, the test strip batch number, the test strip validity period, the storage medium password, the clinical index reference value, and the test strip manufacturer information are stored in the same batch of quantum dot labeling strip 2 quantitative sample concentration. Etc., and can read information such as the identity information of the object to be tested, the information of the detector, the name of the sample, the sample number, the date of detection, and the test result.
所述存贮介质13储存的被检物标准曲线有多种形式可供选择,其包括但不限于被检物标准品系列浓度与OD检测带之间的对应关系曲线。所述OD检测带定义为被检物标准品系列浓度测得的检测带光密度值。The standard curve of the test object stored in the storage medium 13 can be selected in various forms, including but not limited to the corresponding relationship between the concentration of the sample standard series and the OD detection zone . The OD detection zone is defined as the detection band optical density value measured by the concentration of the sample standard series.
所述量子点标记试条2的标记垫5为玻璃纤维膜;所述量子点标记试条2的分析膜7为硝酸纤维素膜、尼龙膜、或硝酸纤维素/醋酸纤维素混合膜;所述量子点标记试条2的底衬1为聚脂或塑料板;所述卡盒3为聚脂、塑料、硬性纸质材料、或其他材料做成。The marking pad 5 of the quantum dot marking strip 2 is a glass fiber membrane; the analysis membrane 7 of the quantum dot marking strip 2 is a nitrocellulose membrane, a nylon membrane, or a nitrocellulose/cellulose acetate mixed membrane; The underlayer 1 of the quantum dot marking strip 2 is a polyester or plastic plate; the cartridge 3 is made of polyester, plastic, hard paper material, or other material.
所述量子点标记试条2为一次性使用品,所述卡盒3及卡盒3上的存贮介质13为同批次量子点标记试条2配套的使用品。The quantum dot marking strip 2 is a disposable product, and the storage medium 13 on the cartridge 3 and the cartridge 3 is a used product matched with the same batch of quantum dot marking strips 2.
所述量子点标记试条卡用于样品检测时,其量子点标记试条2现时插入卡盒3内,插放到卡盒3内的试条2的过盈伸出端浸渍吸取液体样品。液体样品在试条2上完成试条反应后,由具有信号检测功能的仪器(如读条仪、荧光检测仪等)采集试条2检测带6的特征信号并结合该仪器从试条卡存贮介质13同时读取来的被检物标准曲线或系数参数而计算获得样品
单组分或多组分浓度。When the quantum dot marking test strip card is used for sample detection, the quantum dot marking test strip 2 is currently inserted into the cartridge 3, and the liquid protruding sample is immersed in the interference protruding end of the test strip 2 inserted into the cartridge 3 to suck the liquid sample. After the liquid sample is subjected to the test strip reaction on the test strip 2, the characteristic signal of the strip 2 is collected by the instrument having the signal detecting function (such as a reading instrument, a fluorescence detector, etc.) and combined with the instrument to store the strip from the strip. The storage medium 13 simultaneously reads the standard curve or coefficient parameter of the test object and calculates the sample.
Single or multi-component concentration.
所述量子点标记试条卡的待检样品可以是来自临床或非临床的血液、体液、尿液、唾液、生殖道分泌物或其他液态样品或粘稠状样品,其中,临床样品包括传染病、激素、心血管病、肿瘤、癌症、糖尿病、自身免疫病等在内的样品,非临床样品包括食品检测、环境污染检测、农药残留量检测、生物沾染检测、生物制剂检测、兽医学检测、毒品检测等在内的样品。The sample to be tested of the quantum dot-labeled test strip card may be from clinical or non-clinical blood, body fluid, urine, saliva, genital tract secretion or other liquid sample or viscous sample, wherein the clinical sample includes infectious diseases Samples such as hormones, cardiovascular diseases, tumors, cancer, diabetes, autoimmune diseases, etc. Non-clinical samples include food testing, environmental pollution testing, pesticide residue testing, biological contamination testing, biological agent testing, veterinary testing, Samples such as drug testing.
实施例二 Embodiment 2
图5-8说明实施例二。实施例二为本发明所述量子点标记试条卡的另一优选方案。Figures 5-8 illustrate a second embodiment. Embodiment 2 is another preferred embodiment of the quantum dot marking strip card of the present invention.
图5-8中,所述优选方案的所述量子点标记试条卡包括卡盒3和量子点标记试条2。所述量子点标记试条2包括顺次搭接固定在底衬1上的吸样垫4、标记垫5、分析膜7、吸水垫8和试条反应终点指示标签9。分析膜7具有检测带6。卡盒3的一端连同该卡盒端的上盒面开口形成试条插槽口12,以方便量子点标记试条2能现时插入卡盒3内。试条2为卡盒3的离式即插结构。样品检测时,插放到卡盒3内的试条2其吸样垫4一端过盈伸出卡盒3的开口端以浸渍吸取样品。卡盒3的上盒面在对应于试条分析膜7位置处开有检测窗10,卡盒3的上盒面在对应于试条反应终点指示标签9位置处开有观察窗11,卡盒3上安装有一存贮介质13。In Figures 5-8, the quantum dot marking strip card of the preferred embodiment comprises a cartridge 3 and a quantum dot marking strip 2. The quantum dot marking strip 2 includes a sample pad 4, a marker pad 5, an analysis film 7, an absorbent pad 8 and a test strip reaction end indicating label 9 which are sequentially attached to the substrate 1. The analysis membrane 7 has a detection strip 6. One end of the cartridge 3 and the upper opening of the cartridge end form a test strip slot 12 to facilitate insertion of the quantum dot marking strip 2 into the cartridge 3. The test strip 2 is a separate insertion structure of the cartridge 3. At the time of sample detection, the test strip 2 inserted into the cartridge 3 has one end of the sample pad 4 interfering with the open end of the cartridge 3 to be immersed to suck the sample. The upper casing of the cartridge 3 is provided with a detection window 10 at a position corresponding to the test strip analysis film 7, and the upper casing of the cartridge 3 is provided with an observation window 11 at a position corresponding to the test strip end point indicating label 9, the cartridge A storage medium 13 is mounted on the third.
所述量子点标记试条2的标记垫5包被有单一量子点标记的某一目标被检物检测相关的单一特异分子,或:包被有不同单一量子点对应标记的各目标被检物检测相关的特异分子的混合物。试条标记垫5的所述单一量子点可选用以下颗粒,包括ZnS、CdS、HgS、ZnSe、CdSe、HgSe、CdTe、ZnTe、ZnO、PbSe、HgTe、CaAs、InP、InAs、InCaAs、CdS/ZnS、CdS/Ag2S、CdS/PbS、CdS/Cd(OH)2、CdS/HgS、CdS/HgS/CdS、ZnS/CdS、ZnS/CdS/ZnS、ZnS/HgS/ZnS/CdS、CdSe/CdS、CdSe/ZnS、CdSe/ZnSe、CdSe/CuSe、CdSe/HgTe、CdSe/HgSe、CdSe/HgSe/CdSe、CdTe/HgS、CdTe/HgTe、InAs/InP、InAs/CdSe、InAs/ZnSe、MgS、MgSe、MgTe、CaS、CaSe、CaTe、SrS、SrSe、SeTe、BaS、BaSe、BaTe、CdS:Mn、ZnS:Mn、CdS:Cu、ZnS:Cu、CdS:Tb、ZnS:Tb中的任意一种或任意几种纳米粒子的组合,以及由上述任意一种量子点为核、二氧化硅为壳的核-壳型纳米复合粒子。The marking pad 5 of the quantum dot marking strip 2 is coated with a single specific molecule related to a target detection of a single quantum dot label, or: a target analyte coated with a label corresponding to a single quantum dot A mixture of related specific molecules is detected. The single quantum dot of the strip mark pad 5 may be selected from the group consisting of ZnS, CdS, HgS, ZnSe, CdSe, HgSe, CdTe, ZnTe, ZnO, PbSe, HgTe, CaAs, InP, InAs, InCaAs, CdS/ZnS. , CdS/Ag 2 S, CdS/PbS, CdS/Cd(OH) 2 , CdS/HgS, CdS/HgS/CdS, ZnS/CdS, ZnS/CdS/ZnS, ZnS/HgS/ZnS/CdS, CdSe/CdS , CdSe/ZnS, CdSe/ZnSe, CdSe/CuSe, CdSe/HgTe, CdSe/HgSe, CdSe/HgSe/CdSe, CdTe/HgS, CdTe/HgTe, InAs/InP, InAs/CdSe, InAs/ZnSe, MgS, MgSe Any one of MgTe, CaS, CaSe, CaTe, SrS, SrSe, SeTe, BaS, BaSe, BaTe, CdS: Mn, ZnS: Mn, CdS: Cu, ZnS: Cu, CdS: Tb, ZnS: Tb or A combination of any of several kinds of nanoparticles, and a core-shell type nanocomposite particle in which any one of the above quantum dots is a core and silica is a shell.
所述量子点标记试条2的检测带6可以为一条(图5和图6所示),也可以为多条(图7和图8所示)。检测带6包被有某一目标被检物检测相关的另一特异分子,或:包被有各目标被检物检测相关的另一特异分子的混合物。The detection strip 6 of the quantum dot marking strip 2 may be one (shown in FIGS. 5 and 6) or a plurality of strips (shown in FIGS. 7 and 8). The test strip 6 is coated with another specific molecule associated with detection of a target analyte, or a mixture of another specific molecule coated with detection of each target analyte.
所述试条反应终点指示标签9包括变色范围为5-9的pH试纸。样品检测时,试条上的试条反应终点指示标签9能根据试条反应的pH条件而显色,以提示试条反应物是否已充分渗移过检测带6,提示试条反应是否充分,其检测结果是否有效。The strip reaction end point indicating label 9 includes a pH test strip having a discoloration range of 5-9. When the sample is tested, the test strip reaction end point label 9 on the test strip can be colored according to the pH condition of the test strip reaction, to indicate whether the test strip reactant has fully oozing through the test strip 6, indicating whether the test strip reaction is sufficient, Whether the test result is valid.
所述存贮介质13包括但不限于RFID标签、IC芯片、磁码、或条码等。其储存有同批次量子点标记试条2定量样品浓度用的被检物标准曲线或系数参数、试条批号、试条效期、存贮介质密码、临床指标参考值、试条生产厂商信息等,且可读入被测对象身份信息、检测者信息、样品名称、样品编号、检测日期、检测结果等信息。The storage medium 13 includes, but is not limited to, an RFID tag, an IC chip, a magnetic code, or a barcode. The standard curve or coefficient parameter of the test object, the test strip batch number, the test strip validity period, the storage medium password, the clinical index reference value, and the test strip manufacturer information are stored in the same batch of quantum dot labeling strip 2 quantitative sample concentration. Etc., and can read information such as the identity information of the object to be tested, the information of the detector, the name of the sample, the sample number, the date of detection, and the test result.
所述存贮介质13储存的被检物标准曲线有多种形式可供选择,其包括但不限于被检物标准品系列浓度与OD检测带之间的对应关系曲线。所述OD检测带定义为被检物标准品系列浓度测得的检测带光密度值。The standard curve of the test object stored in the storage medium 13 can be selected in various forms, including but not limited to the corresponding relationship between the concentration of the sample standard series and the OD detection zone . The OD detection zone is defined as the detection band optical density value measured by the concentration of the sample standard series.
所述量子点标记试条2的标记垫5为玻璃纤维膜;所述量子点标记试条2的分析膜7为
硝酸纤维素膜、尼龙膜、或硝酸纤维素/醋酸纤维素混合膜;所述量子点标记试条2的底衬1为聚脂或塑料板;所述卡盒3为聚脂、塑料、硬性纸质材料、或其他材料做成。The marking pad 5 of the quantum dot marking strip 2 is a glass fiber membrane; the analysis membrane 7 of the quantum dot marking strip 2 is
a nitrocellulose membrane, a nylon membrane, or a nitrocellulose/cellulose acetate mixed membrane; the bottom liner 1 of the quantum dot marking strip 2 is a polyester or plastic plate; the cartridge 3 is polyester, plastic, rigid Made of paper materials or other materials.
所述量子点标记试条2为一次性使用品。所述卡盒3及卡盒3上的存贮介质13为同批次量子点标记试条2配套的使用品。The quantum dot marking strip 2 is a disposable product. The storage medium 13 on the cartridge 3 and the cartridge 3 is used for the same batch of quantum dot marking strips 2.
所述量子点标记试条卡用于样品检测时,其量子点标记试条2现时插入卡盒3内,插放到卡盒3内的试条2的过盈伸出端浸渍吸取液体样品。试条反应终点指示标签9显色指示样品在试条2上完成试条反应后,由具有信号检测功能的仪器(如读条仪、荧光检测仪等)采集试条2检测带6的特征信号并结合该仪器从试条卡存贮介质13同时读取来的被检物标准曲线或系数参数而计算获得样品单组分或多组分浓度。When the quantum dot marking test strip card is used for sample detection, the quantum dot marking test strip 2 is currently inserted into the cartridge 3, and the liquid protruding sample is immersed in the interference protruding end of the test strip 2 inserted into the cartridge 3 to suck the liquid sample. Test strip reaction end point indication label 9 color display indicator After the strip test is completed on the test strip 2, the characteristic signal of the test strip 2 is detected by the instrument having the signal detection function (such as a reading instrument, a fluorescence detector, etc.) The single component or multi-component concentration of the sample is calculated by combining the standard curve or coefficient parameter of the sample simultaneously read from the test strip storage medium 13 by the instrument.
所述量子点标记试条卡的待检样品可以是来自临床或非临床的血液、体液、尿液、唾液、生殖道分泌物或其他液态样品或粘稠状样品,其中,临床样品包括传染病、激素、心血管病、肿瘤、癌症、糖尿病、自身免疫病等在内的样品,非临床样品包括食品检测、环境污染检测、农药残留量检测、生物沾染检测、生物制剂检测、兽医学检测、毒品检测等在内的样品。The sample to be tested of the quantum dot-labeled test strip card may be from clinical or non-clinical blood, body fluid, urine, saliva, genital tract secretion or other liquid sample or viscous sample, wherein the clinical sample includes infectious diseases Samples such as hormones, cardiovascular diseases, tumors, cancer, diabetes, autoimmune diseases, etc. Non-clinical samples include food testing, environmental pollution testing, pesticide residue testing, biological contamination testing, biological agent testing, veterinary testing, Samples such as drug testing.
需要指出的是,本发明所述的量子点标记的试条卡还可以有其它改进,如存储有被检物标准曲线等检测用信息的存贮介质13除了安装在试条卡的卡盒3上外,还可直接安装在量子点标记试条2上;基于本发明相同原理,插放到卡盒3内的量子点标记试条还可扩展替换为量子点标记的生物芯片(包括抗原抗体芯片、蛋白芯片、核酸芯片、微流控芯片)等等。因此,凡是对本发明所述量子点标记试条卡采用任何等同替换或等效变换形成的其它技术方案,均落在本发明权利要求的保护范围中。
It should be noted that the quantum dot-labeled test strip card of the present invention may have other improvements, such as a storage medium 13 storing detection information such as a test sample standard curve, in addition to the cartridge 3 mounted on the test strip card. Above and outside, it can also be directly mounted on the quantum dot marking strip 2; based on the same principle of the invention, the quantum dot marking strip inserted into the cartridge 3 can also be extended to replace the quantum dot labeled biochip (including antigenic antibodies). Chips, protein chips, nucleic acid chips, microfluidic chips, etc. Therefore, any other technical solution formed by any equivalent replacement or equivalent transformation of the quantum dot-labeled test strip card of the present invention falls within the scope of protection of the present invention.
Claims (18)
- 一种量子点标记的试条卡,包括卡盒(3)和量子点标记试条(2),量子点标记试条(2)包括顺次搭接固定在底衬(1)上的吸样垫(4)、标记垫(5)、分析膜(7)、吸水垫(8),分析膜(7)具有检测带(6),检测带(6)为一条或多条,卡盒(3)的上盒面在对应于试条分析膜(7)位置处开有检测窗(10),其特征在于:A quantum dot-labeled test strip card comprising a cartridge (3) and a quantum dot marking strip (2), the quantum dot marking strip (2) comprising a sample attached to the substrate (1) in a sequential overlap Pad (4), marking pad (5), analysis film (7), absorbent pad (8), analysis film (7) has detection tape (6), detection tape (6) is one or more, and the cartridge (3) The upper box surface has a detection window (10) at a position corresponding to the strip analysis film (7), which is characterized by:所述卡盒(3)的一端连同该卡盒端的上盒面开口形成试条插槽口(12),试条(2)为卡盒(3)的离式即插结构,样品检测时,插放到卡盒(3)内的试条(2)其吸样垫(4)一端过盈伸出卡盒(3)开口端以浸渍吸取样品;One end of the card box (3) and the upper box surface opening of the card box end form a test strip slot (12), and the test strip (2) is a separate plug-in structure of the card box (3), when the sample is tested, a test strip (2) inserted into the cartridge (3), one end of the suction pad (4) is over-extended to extend out of the open end of the cartridge (3) to dip the sample;所述卡盒(3)上安装有一存贮介质(13);The storage box (3) is mounted with a storage medium (13);所述量子点标记试条(2)的标记垫(5)包被有单一量子点标记的某一目标被检物检测相关的单一特异分子,或:包被有不同单一量子点对应标记的各目标被检物检测相关的特异分子的混合物;The marking pad (5) of the quantum dot marking strip (2) is coated with a single quantum dot-labeled target specific analyte for detecting a single specific molecule, or: each coated with a different single quantum dot corresponding label Target analytes detect a mixture of related specific molecules;所述量子点标记试条(2)的检测带(6)包被有某一目标被检物检测相关的另一特异分子,或:包被有各目标被检物检测相关的另一特异分子的混合物。The detection band (6) of the quantum dot labeling strip (2) is coated with another specific molecule associated with detection of a target analyte, or: another specific molecule coated with detection of each target analyte mixture.
- 根据权利要求1所述的量子点标记的试条卡,其特征在于:其中所述量子点标记试条(2)的标记垫(5)的所述单一量子点包括ZnS、CdS、HgS、ZnSe、CdSe、HgSe、CdTe、ZnTe、ZnO、PbSe、HgTe、CaAs、InP、InAs、InCaAs、CdS/ZnS、CdS/Ag2S、CdS/PbS、CdS/Cd(0H)2、CdS/HgS、CdS/HgS/CdS、ZnS/CdS、ZnS/CdS/ZnS、ZnS/HgS/ZnS/CdS、CdSe/CdS、CdSe/ZnS、CdSe/ZnSe、CdSe/CuSe、CdSe/HgTe、CdSe/HgSe、CdSe/HgSe/CdSe、CdTe/HgS、CdTe/HgTe、InAs/InP、InAs/CdSe、InAs/ZnSe、MgS、MgSe、MgTe、CaS、CaSe、CaTe、SrS、SrSe、SeTe、BaS、BaSe、BaTe、CdS:Mn、ZnS:Mn、CdS:Cu、ZnS:Cu、CdS:Tb、ZnS:Tb中的任意一种或任意几种纳米粒子的组合,以及由上述任意一种量子点为核、二氧化硅为壳的核-壳型纳米复合粒子。The quantum dot-labeled test strip card according to claim 1, wherein said single quantum dot of said marking pad (5) of said quantum dot marking strip (2) comprises ZnS, CdS, HgS, ZnSe , CdSe, HgSe, CdTe, ZnTe, ZnO, PbSe, HgTe, CaAs, InP, InAs, InCaAs, CdS/ZnS, CdS/Ag 2 S, CdS/PbS, CdS/Cd(0H) 2 , CdS/HgS, CdS /HgS/CdS, ZnS/CdS, ZnS/CdS/ZnS, ZnS/HgS/ZnS/CdS, CdSe/CdS, CdSe/ZnS, CdSe/ZnSe, CdSe/CuSe, CdSe/HgTe, CdSe/HgSe, CdSe/HgSe /CdSe, CdTe/HgS, CdTe/HgTe, InAs/InP, InAs/CdSe, InAs/ZnSe, MgS, MgSe, MgTe, CaS, CaSe, CaTe, SrS, SrSe, SeTe, BaS, BaSe, BaTe, CdS: Mn , ZnS: Mn, CdS: Cu, ZnS: Cu, CdS: Tb, ZnS: Tb, or a combination of any of several kinds of nanoparticles, and any one of the above quantum dots is a core, and silica is a shell Core-shell nanocomposite particles.
- 根据权利要求1所述的量子点标记的试条卡,其特征在于:所述存贮介质(13)包括RFID标签、IC芯片、磁码、或条码。The quantum dot-labeled test strip card of claim 1 wherein said storage medium (13) comprises an RFID tag, an IC chip, a magnetic code, or a barcode.
- 根据权利要求1所述的量子点标记的试条卡,其特征在于:所述存贮介质(13)储存有同批次量子点标记试条(2)定量样品浓度用的被检物标准曲线或系数参数、试条批号、试条效期、存贮介质密码、临床指标参考值、试条生产厂商信息,且可读入被测对象身份信息、检测者信息、样品名称、样品编号、检测日期、检测结果信息。The quantum dot-labeled test strip card according to claim 1, wherein the storage medium (13) stores the same batch of quantum dot-labeled test strips (2) the standard curve of the sample for quantitative sample concentration Or coefficient parameter, test strip batch number, test strip validity period, storage medium password, clinical index reference value, test strip manufacturer information, and can read the object identification information, detector information, sample name, sample number, detection Date, test result information.
- 根据权利要求4所述的量子点标记的试条卡,其特征在于:所述存贮介质(13)储存的被检物标准曲线有多种形式可供选择,其包括被检物标准品系列浓度与OD检测带之间的对应关系曲线;所述OD检测带定义为被检物标准品系列浓度测得的检测带光密度值。The quantum dot-labeled test strip card according to claim 4, wherein the standard curve of the test object stored in the storage medium (13) has various forms to be selected, and includes a standard sample series of the test object. A correspondence curve between the concentration and the OD detection zone ; the OD detection zone is defined as a detection band optical density value measured by the concentration of the sample standard series.
- 根据权利要求1所述的量子点标记的试条卡,其特征在于:The quantum dot-labeled test strip card according to claim 1, wherein:所述量子点标记试条(2)的标记垫(5)为玻璃纤维膜,所述量子点标记试条(2)的分析膜(7)为硝酸纤维素膜、尼龙膜、或硝酸纤维素/醋酸纤维素混合膜;The marking pad (5) of the quantum dot marking strip (2) is a glass fiber membrane, and the analysis membrane (7) of the quantum dot marking strip (2) is a nitrocellulose membrane, a nylon membrane, or a nitrocellulose / cellulose acetate mixed film;所述量子点标记试条(2)的底衬(1)为聚脂或塑料板; The underlayer (1) of the quantum dot marking strip (2) is a polyester or plastic plate;所述卡盒(3)为聚脂、塑料、或硬性纸质材料做成。The cartridge (3) is made of polyester, plastic, or a hard paper material.
- 根据权利要求1所述的量子点标记的试条卡,其特征在于:其中所述量子点标记试条(2)为一次性使用品,所述卡盒(3)及卡盒(3)上的存贮介质(13)为同批次量子点标记试条(2)配套的使用品。The quantum dot-labeled test strip card according to claim 1, wherein said quantum dot marking test strip (2) is a disposable product, said cartridge (3) and said cartridge (3) The storage medium (13) is used for the same batch of quantum dot marking strips (2).
- 根据权利要求1所述的量子点标记的试条卡,其特征在于:样品检测时,量子点标记试条(2)现时插入卡盒(3)内,插放到卡盒(3)内的试条(2)的过盈伸出端浸渍吸取样品,样品在试条(2)上完成试条反应后,由具有信号检测功能的仪器采集卡盒(3)内试条(2)检测带(6)的特征信号并结合该仪器从存贮介质(13)同时读取的被检物标准曲线或系数参数而计算获得样品单组分或多组分浓度。The quantum dot-labeled test strip card according to claim 1, wherein when the sample is detected, the quantum dot marking test strip (2) is currently inserted into the cartridge (3) and inserted into the cartridge (3). The interference protruding end of the test strip (2) is immersed to suck the sample, and after the sample is reacted on the test strip (2), the test strip is collected by the instrument with the signal detection function (3) the inner test strip (2) the test strip The characteristic signal of (6) is calculated in conjunction with the standard curve or coefficient parameter of the test object simultaneously read by the instrument from the storage medium (13) to obtain a single component or multi-component concentration of the sample.
- 一种如权利要求1所述的量子点标记的试条卡,其特征在于:其中所述量子点标记试条(2)的吸水垫(8)之后还搭接有一试条反应终点指示标签(9);其卡盒(3)的该试条反应终点指示标签(9)相应处开有观察窗(11)。A quantum dot-labeled test strip card according to claim 1, wherein the water-absorbing pad (8) of the quantum dot-labeled test strip (2) is further overlapped with a test strip reaction end point indicating label ( 9); the test strip of the cartridge (3) reflects the end point indication label (9) with an observation window (11) correspondingly.
- 根据权利要求9所述的量子点标记的试条卡,其特征在于,所述试条反应终点指示标签(9)包括变色范围为5-9的pH试纸。The quantum dot-labeled test strip card according to claim 9, wherein the test strip reaction end point indicating label (9) comprises a pH test strip having a discoloration range of 5-9.
- 根据权利要求9所述的量子点标记的试条卡,其特征在于:其中所述量子点标记试条(2)的标记垫(5)的所述单一量子点包括ZnS、CdS、HgS、ZnSe、CdSe、HgSe、CdTe、ZnTe、ZnO、PbSe、HgTe、CaAs、InP、InAs、InCaAs、CdS/ZnS、CdS/Ag2S、CdS/PbS、CdS/Cd(0H)2、CdS/HgS、CdS/HgS/CdS、ZnS/CdS、ZnS/CdS/ZnS、ZnS/HgS/ZnS/CdS、CdSe/CdS、CdSe/ZnS、CdSe/ZnSe、CdSe/CuSe、CdSe/HgTe、CdSe/HgSe、CdSe/HgSe/CdSe、CdTe/HgS、CdTe/HgTe、InAs/InP、InAs/CdSe、InAs/ZnSe、MgS、MgSe、MgTe、CaS、CaSe、CaTe、SrS、SrSe、SeTe、BaS、BaSe、BaTe、CdS:Mn、ZnS:Mn、CdS:Cu、ZnS:Cu、CdS:Tb、ZnS:Tb中的任意一种或任意几种纳米粒子的组合,以及由上述任意一种量子点为核、二氧化硅为壳的核-壳型纳米复合粒子。The quantum dot-labeled test strip card according to claim 9, wherein said single quantum dot of said marking pad (5) of said quantum dot marking strip (2) comprises ZnS, CdS, HgS, ZnSe , CdSe, HgSe, CdTe, ZnTe, ZnO, PbSe, HgTe, CaAs, InP, InAs, InCaAs, CdS/ZnS, CdS/Ag 2 S, CdS/PbS, CdS/Cd(0H) 2 , CdS/HgS, CdS /HgS/CdS, ZnS/CdS, ZnS/CdS/ZnS, ZnS/HgS/ZnS/CdS, CdSe/CdS, CdSe/ZnS, CdSe/ZnSe, CdSe/CuSe, CdSe/HgTe, CdSe/HgSe, CdSe/HgSe /CdSe, CdTe/HgS, CdTe/HgTe, InAs/InP, InAs/CdSe, InAs/ZnSe, MgS, MgSe, MgTe, CaS, CaSe, CaTe, SrS, SrSe, SeTe, BaS, BaSe, BaTe, CdS: Mn , ZnS: Mn, CdS: Cu, ZnS: Cu, CdS: Tb, ZnS: Tb, or a combination of any of several kinds of nanoparticles, and any one of the above quantum dots is a core, and silica is a shell Core-shell nanocomposite particles.
- 根据权利要求9所述的量子点标记的试条卡,其特征在于:所述存贮介质(13)包括RFID标签、IC芯片、磁码、或条码。A quantum dot-labeled test strip card according to claim 9, wherein said storage medium (13) comprises an RFID tag, an IC chip, a magnetic code, or a barcode.
- 根据权利要求9所述的量子点标记的试条卡,其特征在于:所述存贮介质(13)储存有同批次量子点标记试条(2)定量样品浓度用的被检物标准曲线或系数参数、试条批号、试条效期、存贮介质密码、临床指标参考值、试条生产厂商信息,且可读入被测对象身份信息、检测者信息、样品名称、样品编号、检测日期、检测结果信息。The quantum dot-labeled test strip according to claim 9, wherein the storage medium (13) stores the same batch of quantum dot-labeled test strips (2) the standard curve of the sample for quantitative sample concentration Or coefficient parameter, test strip batch number, test strip validity period, storage medium password, clinical index reference value, test strip manufacturer information, and can read the object identification information, detector information, sample name, sample number, detection Date, test result information.
- 根据权利要求13所述的量子点标记的试条卡,其特征在于:所述存贮介质(13)储存的被检物标准曲线有多种形式可供选择,其包括被检物标准品系列浓度与OD检测带之间的对应关系曲线;所述OD检测带定义为被检物标准品系列浓度测得的检测带光密度值。The quantum dot-labeled test strip card according to claim 13, characterized in that the standard curve of the test object stored in the storage medium (13) has various forms to be selected, which includes the standard sample series of the test object. A correspondence curve between the concentration and the OD detection zone ; the OD detection zone is defined as a detection band optical density value measured by the concentration of the sample standard series.
- 根据权利要求9所述的量子点标记的试条卡,其特征在于:The quantum dot-labeled test strip card according to claim 9, wherein:所述量子点标记试条(2)的标记垫(5)为玻璃纤维膜,所述量子点标记试条(2)的分析膜(7)为硝酸纤维素膜、尼龙膜、或硝酸纤维素/醋酸纤维素混合膜; The marking pad (5) of the quantum dot marking strip (2) is a glass fiber membrane, and the analysis membrane (7) of the quantum dot marking strip (2) is a nitrocellulose membrane, a nylon membrane, or a nitrocellulose / cellulose acetate mixed film;所述量子点标记试条(2)的底衬(1)为聚脂或塑料板;The underlayer (1) of the quantum dot marking strip (2) is a polyester or plastic plate;所述卡盒(3)为聚脂、塑料、或硬性纸质材料做成。The cartridge (3) is made of polyester, plastic, or a hard paper material.
- 根据权利要求9所述的量子点标记的试条卡,其特征在于:其中所述量子点标记试条(2)为一次性使用品,所述卡盒(3)及卡盒(3)上的存贮介质(13)为同批次量子点标记试条(2)配套的使用品。The quantum dot-labeled test strip card according to claim 9, wherein said quantum dot marking test strip (2) is a disposable product, said cartridge (3) and said cartridge (3) The storage medium (13) is used for the same batch of quantum dot marking strips (2).
- 根据权利要求9所述的量子点标记的试条卡,其特征在于:样品检测时,量子点标记试条(2)现时插入卡盒(3)内,插放到卡盒(3)内的试条(2)的过盈伸出端浸渍吸取样品,试条反应终点指示标签(9)指示样品在试条(2)上完成试条反应后,由具有信号检测功能的仪器采集卡盒(3)内试条(2)检测带(6)的特征信号并结合该仪器从存贮介质(13)同时读取的被检物标准曲线或系数参数而计算获得样品单组分或多组分浓度。The quantum dot-labeled test strip card according to claim 9, wherein when the sample is detected, the quantum dot marking test strip (2) is currently inserted into the cartridge (3) and inserted into the cartridge (3). The interference protruding end of the test strip (2) is immersed to suck the sample, and the test strip reaction end indication label (9) indicates that after the sample is reacted on the test strip (2), the cassette is collected by the instrument having the signal detecting function ( 3) The inner test strip (2) detects the characteristic signal of the strip (6) and calculates the one-component or multi-component of the sample by combining the standard curve or coefficient parameter of the test object read simultaneously from the storage medium (13). concentration.
- 一种如权利要求1或9所述的量子点标记的试条卡,其特征在于:待检样品是来自临床或非临床的血液、体液、尿液、唾液、生殖道分泌物或其他液态样品或粘稠状样品,其中,临床样品包括传染病、激素、心血管病、肿瘤、癌症、糖尿病、自身免疫病在内的样品,非临床样品包括食品检测、环境污染检测、农药残留量检测、生物沾染检测、生物制剂检测、兽医学检测、毒品检测在内的样品。 A quantum dot-labeled test strip according to claim 1 or 9, wherein the sample to be tested is from clinical or non-clinical blood, body fluid, urine, saliva, genital secretions or other liquid samples. Or viscous samples, including clinical samples including infectious diseases, hormones, cardiovascular diseases, tumors, cancer, diabetes, autoimmune diseases, non-clinical samples including food testing, environmental pollution testing, pesticide residue testing, Samples for bio-contamination testing, biologics testing, veterinary testing, and drug testing.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310564765.3A CN103675267A (en) | 2013-11-14 | 2013-11-14 | Test strip card based on quantum dot labeling |
CN201310564765.3 | 2013-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015070746A1 true WO2015070746A1 (en) | 2015-05-21 |
Family
ID=50313453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2014/090849 WO2015070746A1 (en) | 2013-11-14 | 2014-11-11 | Test strip card marked by quantum dots |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103675267A (en) |
WO (1) | WO2015070746A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103630682A (en) * | 2013-11-12 | 2014-03-12 | 成都领御生物技术有限公司 | Test strip card based on quantum dot labeling |
CN103630685A (en) * | 2013-11-13 | 2014-03-12 | 成都领御生物技术有限公司 | Test strip card |
CN103675267A (en) * | 2013-11-14 | 2014-03-26 | 成都领御生物技术有限公司 | Test strip card based on quantum dot labeling |
CN103645313A (en) * | 2013-11-16 | 2014-03-19 | 成都领御生物技术有限公司 | Test strip card |
CN105319359B (en) * | 2014-08-18 | 2017-02-08 | 董俊 | Streptococcus pneumoniae quantum dot immunochromatographic assay detection card and preparing method and application thereof |
CN105510609A (en) * | 2015-11-26 | 2016-04-20 | 宁波美康保生生物医学工程有限公司 | In vitro test piece and application method thereof |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101368907A (en) * | 2008-07-14 | 2009-02-18 | 马义才 | Quantum dot marking test strip quantitative detection system based on CMOS image sensor |
CN101514987A (en) * | 2008-07-14 | 2009-08-26 | 马义才 | System for quantitative detection of quanta dot mark test bar and detection method thereof |
CN201724940U (en) * | 2009-12-22 | 2011-01-26 | 王继华 | Immunochromatographic test strip with bar code layer |
CN103091486A (en) * | 2011-11-01 | 2013-05-08 | 马义才 | Test strip detection system |
CN103267843A (en) * | 2013-06-08 | 2013-08-28 | 张沈平 | Colloidal gold test paper as well as corresponding colloidal gold analyzer and testing method |
CN103630682A (en) * | 2013-11-12 | 2014-03-12 | 成都领御生物技术有限公司 | Test strip card based on quantum dot labeling |
CN103675267A (en) * | 2013-11-14 | 2014-03-26 | 成都领御生物技术有限公司 | Test strip card based on quantum dot labeling |
CN203759012U (en) * | 2013-11-14 | 2014-08-06 | 成都领御生物技术有限公司 | Quantum dot labeled test strip card |
CN203759010U (en) * | 2013-11-12 | 2014-08-06 | 成都领御生物技术有限公司 | Quantum dot labeled test strip card |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101769925A (en) * | 2009-12-22 | 2010-07-07 | 王继华 | Method and system for intelligently identifying and reading immunity-chromatography test strip and application thereof |
-
2013
- 2013-11-14 CN CN201310564765.3A patent/CN103675267A/en active Pending
-
2014
- 2014-11-11 WO PCT/CN2014/090849 patent/WO2015070746A1/en active Application Filing
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101368907A (en) * | 2008-07-14 | 2009-02-18 | 马义才 | Quantum dot marking test strip quantitative detection system based on CMOS image sensor |
CN101514987A (en) * | 2008-07-14 | 2009-08-26 | 马义才 | System for quantitative detection of quanta dot mark test bar and detection method thereof |
CN201724940U (en) * | 2009-12-22 | 2011-01-26 | 王继华 | Immunochromatographic test strip with bar code layer |
CN103091486A (en) * | 2011-11-01 | 2013-05-08 | 马义才 | Test strip detection system |
CN103267843A (en) * | 2013-06-08 | 2013-08-28 | 张沈平 | Colloidal gold test paper as well as corresponding colloidal gold analyzer and testing method |
CN103630682A (en) * | 2013-11-12 | 2014-03-12 | 成都领御生物技术有限公司 | Test strip card based on quantum dot labeling |
CN203759010U (en) * | 2013-11-12 | 2014-08-06 | 成都领御生物技术有限公司 | Quantum dot labeled test strip card |
CN103675267A (en) * | 2013-11-14 | 2014-03-26 | 成都领御生物技术有限公司 | Test strip card based on quantum dot labeling |
CN203759012U (en) * | 2013-11-14 | 2014-08-06 | 成都领御生物技术有限公司 | Quantum dot labeled test strip card |
Also Published As
Publication number | Publication date |
---|---|
CN103675267A (en) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015070745A1 (en) | Test strip card marked by quantum dots | |
WO2015070699A1 (en) | Quantum dot-labeled test strip card | |
WO2015070700A1 (en) | Quantum dot-labeled test strip card | |
WO2015070702A1 (en) | Test strip card | |
WO2015070701A1 (en) | Test strip card | |
WO2015070746A1 (en) | Test strip card marked by quantum dots | |
CN203759009U (en) | Quantum dot labeled test strip card | |
WO2015070747A1 (en) | Test strip card | |
JP5908101B2 (en) | Test strip detection system | |
CN203759015U (en) | Test strip card | |
WO2015070704A1 (en) | Test bar card | |
US7323139B2 (en) | Accessible assay and method of use | |
WO2015070750A1 (en) | Test strip card | |
US8470608B2 (en) | Combined visual/fluorescence analyte detection test | |
WO2015070748A1 (en) | Test strip card | |
CN203759017U (en) | Test strip card | |
WO2015070749A1 (en) | Test strip card | |
CN203759014U (en) | Test strip card | |
CN203759011U (en) | Quantum dot labeled test strip card | |
WO2015070703A1 (en) | Test strip card | |
WO2009152209A2 (en) | Combined visual/fluorescence analyte detection test | |
US20170336404A1 (en) | Rapid immunoassays | |
CN203759012U (en) | Quantum dot labeled test strip card | |
CN203759016U (en) | Test strip card | |
CN203606364U (en) | Test strip card |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14861401 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14861401 Country of ref document: EP Kind code of ref document: A1 |